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INTRODUCTION
Mass  lesions  in  the  uterus  are  a  commonly  encountered  problem all  over  the 
world.  15 to 20% of women in the reproductive age group have mass lesions in the 
uterus38.  In the Institute of Obstetrics and Gynaecology,  Egmore, Chennai, about 800 
hysterectomies were done for benign pathology in the year 2004.  Among them 45% had 
fibroid uterus and 25% had adenomyosis.  But  less than 5% of total adenomyosis cases 
were diagnosed by Transabdominal ultrasound alone preoperatively.   This necessitated 
the definitive preoperative diagnosis of adenomyosis.  
Over  the  years  many  imaging  modalities  like  Transabdominal  ultrasound, 
Transvaginal  ultrasound,  Colour  Doppler,  Hysterosonosalphingography,  Computerised 
Tomography,  Magnetic  Resonance  Imaging  have  been  tried  to  characterise  the  mass 
lesions.  Even today Transabdominal  ultrasound is the screening imaging modality of 
choice.  
Definitive characterisation of the lesion is important to decide on the treatment 
modality.  For example, in case of myoma, myomectomy or hysterectomy can be done. 
But  in  case  of  Adenomyosis,  hysterectomy  is  the  treatment  of  choice  for  definitive 
cure38,18.  This states the need for a definitive preoperative diagnosis.  
In cases of submucosal fibroid, if the endometrial surface circumference is more 
than  50%  it  can  be  resected  hysteroscopically18.   Otherwise  it  should  be  resected 
laparoscopically.  The same way for intramural fibroids, depending on the number and 
site of the lesion, laparoscopic resection or hysterectomy can be planned.  It states the 
need for exact location and extent of the lesion by various measurements like size and 
circumference.  
To some extent the questions were answered by Transvaginal ultrasound but it 
depends  on  the  operator  and  large  lesions  cannot  be  brought  within  the  field  of 
Transvaginal ultrasound.  
Hysterosonosalphingography is useful only in endometrial lesions.  CT is utilized 
to evaluate uterine lesion mainly in staging the carcinomas.   The continuing need for 
better imaging modality for definitive characterisation of uterine mass lesions lead to the 
use of MRI as a diagnostic tool in preoperative evaluations.  MRI is a recently devised 
modality which is done in sagittal, axial and coronal planes using body surface coil in T1, 
T2 weighted sequences.
This  study  involves  detailed  evaluation  of  uterine  mass  lesions  like  number, 
location, size, other measurements, degenerative changes within the lesions, extent of the 
lesion using Transabdominal ultrasound, Transvaginal ultrasound & MRI. Final diagnosis 
by  imaging  was  compared  with  histopathological  reports.  Comparisons  were  made 
between  the  three  modalities  for  1.  detection  sensitivity  of  each  parameter,  2. 
characterisation & differentiation between lesions,  3.  sensitivity & specificity of each 
modality to make final diagnosis against HPE reports.
AIM
1. To evaluate the MRI characteristics of uterine mass lesions.
2. To compare the sensitivity of MRI, Transabdominal ultrasound, Transvaginal 
ultrasound in characterising the uterine mass lesions.  
3. To assess the accuracy in staging the malignant mass lesions. 
REVIEW OF LITERATURE 
Uterus  is  a  hollow  thick  walled  muscular  organ  consisting  of  muscle  layer 
myometrium  and  inner  mucosal  layer  endometrium  and  outer  peritoneal  surface 
perimetrium37,38. Myometrium forms most of the substance of uterus.  It is divided 
into two major portions, the body and cervix by a slight narrowing at the level of 
internal os.  The fundus is the superior area of the body above entrance of fallopian 
tubes.  The area of the body where the tubes enter the uterus is called cornua37.
Uterus  is  located  between the  two layers  of  broad ligament  laterally,  bladder 
anteriorly and rectosigmoid colon posteriorly.   Round ligaments arise from uterine 
cornua anterior to fallopian tubes in broad ligament, extend antero laterally coursing 
thro the inguinal canal to insert into the fascia of labia majora37.  
Fallopian tubes run laterally from the uterus in the upper free margin of the broad 
ligament.  Each tube varies from 7 to 12 cms in length.  Ovaries are elliptical in shape 
with long axis usually oriented vertically.  Fimbriae of fallopian tubes lie superior and 
lateral to the ovary37.  
Anterior surface of ovary is attached to posterior surface of broad ligament by a 
short meso ovarium.  Lower pole of ovary is attached to uterus by ovarian ligament. 
Upper pole is attached to the lateral wall of the pelvis by lateral extension of broad 
ligament known as suspensary ligament of ovary37.  
Cervix opens into the upper vagina through the external os.  The vagina is a fibro 
muscular canal that lies in the midline and runs from the cervix to the vestibule of 
external genitalia.  The cervix projects into proximal vagina creating a space between 
the vaginal walls and surface of the cervix called vaginal fornix.  Although the space 
is continuous it is divided into anterior, posterior and 2 lateral fornices37.  
Arterial supply to the uterus comes primarily from uterine artery, a major branch 
of anterior trunk of internal iliac artery.  It ascends along the lateral margin of the 
uterus  in  broad  ligament  and  at  the  level  of  uterine  cornua  runs  laterally  to 
anastomose  with  the  ovarian  artery.   The  uterine  arteries  anastomose  extensively 
across  the  midline  through  the  anterior  and  posterior  arcuate  arteries,  which  run 
within the broad ligament and then enter the myometrium.  The uterine plexus of 
veins accompanies the arteries.  
Ovarian artery supplies the ovary.  It is a branch of aorta and anastomoses with 
uterine artery.  Right ovarian vein drains into IVC.  Left ovarian vein drains into left 
renal vein.  
Lymphatic drainage of ovary is to the lateral aortic and peri aortic lymphnodes. 
The lymphatic of fundus, upper uterine body and fallopian tubes accompany those of 
ovary and of the lower uterine body to external iliac nodes.  Whereas those of cervix 
course in three directions.  Laterally to the external iliac lymphnodes, posterolaterally 
to the internal iliac nodes and posteriorly to lateral sacral lymphnodes.  The lymphatic 
of upper vagina to external and internal iliac lymphnodes following uterine artery. 
Whereas those of mid vagina follow vaginal artery branch to internal  iliac  nodes. 
Lower vagina near the orifice joins those of vulva and drain to superficial inguinal 
nodes.  
As stated in the introduction, 15 to 20% of the women in the reproductive age 
group have uterine mass lesions37,38, Imaging plays an integral role in evaluation of 
gynaecological  diseases.   Many  studies  have  proved  the  usefulness  of  MRI  in 
characterising the uterine mass lesions and thereby to make a definitive diagnosis.  
Mass lesions seen commonly in uterus can be divided into 
1. Lesions involving myometrium Leiomyoma
Adenomyosis
Leiomyosarcoma
Rarely Lipoleiomyoma
Malignant lymphoma 
Arteriovenous malformations
2. Lesions involving endometrium Endometrial polyp
Endometrial hyperplasia
Endometrial carcinoma
Endometrial cyst
Hematometrocolpos
Rarely Endometrial stromal sarcoma
3. Lesions involving cervix Nabothian cyst
Cervical polyp
Carcinoma cervix
Rarely Adenoma malignum 
To  correctly  identify  the  abnormalities,  normal  sonographic  and  MRI  appearance  of 
uterus along with cut-off values of various measurements should be known.
SONOGRAPHIC APPEARANCE OF UTERUS
Uterine  measurement  above  8x5x4cms  is  considered  as  enlarged37,36. 
Endometrium is best measured on a midline sagittal scan of uterus and should include 
both anterior and posterior portions of the endometrium.  Endometrial size and thickness 
vary with the menstrual cycle37,36. 
 Endometrium  consists  of  deep  basalis  and  superficial  functional  layer. 
Functionalis layer undergoes changes throughout the menstrual cycle and is shed with 
each menses. Basal layer remains intact during the cycle and contains the spiral arteries. 
 Menstrual  phase  endometrium  consists  of  a  thin  broken  echogenic  line.  In 
proliferative phase endometrium thickens reaching 4 to 8mm.  Endometrial cavity is seen 
as thin echogenic line as a result of specular reflection from the interface between the 
opposing surfaces of the endometrium.  A relatively hypoechoic region that represents 
functional layer can be seen around central echogenic line which becomes more clearly 
defined in late proliferative phase.  Hypoechoic appearance is due to orderly arrangement 
of glandular elements.  It is surrounded by echogenic basal layer37,36.
  In secretory phase functional layer changes from hypoechoic to hyperechoic.  It 
measures 7 to 14mm.  This appearance is due to increased mucus and glycogen within the 
glands as well as due to increased number of interfaces caused by tortuosity of spiral 
arteries.   Following  menopause  endometrium  becomes  atrophic  and  seen  as  thin 
echogenic line.  It should not measure more than 8mm37,36.
Normal myometrium consist of three layers.  Intermediate layer is thickest and 
has uniformly homogenous structure of low to moderate echogenicity.  Inner layer is thin, 
compact which is hypoechoic and surrounds the relatively echogenic endometrium.  It 
has also been referred as sub endometrial halo.  Outer layer is slightly less echogenic than 
intermediate layer and is separated from it by arcuate vessels37.  
MRI APPEARANCE OF UTERUS
Uterus appears as uniformly low signal intensity structure on T1 weighted images 
and no internal anatomy is visualized.  In all pre menopausal women three distinct zones 
within the uterine corpus can be depicted on T2 weighted images.  A central high signal 
intensity stripe corresponds to the endometrium and secretions within the endometrial 
cavity.  This is surrounded by low signal intensity band referred to as junctional zone. 
Histologically it  corresponds to innermost  layer  of myometrium and has an increased 
nuclear area compared with outer myometrium primarily reflecting increased cellularity 
and  decreased  water  content  in  the  junctional  zone  in  comparison  with  outer 
myometrium.   The outer layer of myometrium is of intermediate signal intensity36,31.  
Endometrium varies in thickness during menstrual cycle and measure from 4mm 
to 13mm.  Outer myometrium may vary in signal intensity and width during menstrual 
cycle reaching maximum width of 2.5cm in late secretory phase.  The width of junctional 
zone averages 5mm and does not vary significantly during menstrual cycle31.  
In  postmenopausal  women  as  myometrial  signal  intensity  is  decreased, 
myometrial / junctional zone contrast is decreased and the junctional zone is less easily 
definable and may not always be present. In women taking OCP the endometrium is thin 
and averages 2mm and does not vary in width.   The size of the uterine corpus and width 
of  the  junctional  zone  is  decreased.   Myometrial  signal  intensity  is  increased  due  to 
increased uterine water content31.  
Four distinct zones can be identified in cervix on T2 weighted images.  Central 
stripe  of  high  signal  intensity  represents  mucus  within  the  endocervical  canal. 
Immediately subjacent is zone of intermediate signal intensity most likely representing 
cervical mucosa.  Mucosal folds, the plicae palmata, can often be visualised within this 
layer.   Surrounding  this  layer  is  the  band  of  low  signal  intensity  contiguous  with 
junctional zone of uterine corpus and represents fibrous cervical stroma.  Outer most zone 
is contiguous with the outer zone of myometrium and is isointense.  The MR appearance 
of cervical zonal anatomy does not appear to be hormonally dependent31. 
 On  T1 weighted  gadolinium contrast  enhanced  images  the  zonal  anatomy  is 
variable and depends on timing after injection and the hormonal status of the patients. 
MASS LESIONS; LEIOMYOMA:
Leiomyoma are the most common uterine neoplasm and are composed of smooth 
muscle with varying amounts of fibrous connective tissue37,36.   Most leiomyomas are 
asymptomatic.  Patient  may  present  with  abnormal  uterine  bleeding,  pain,  infertility, 
palpable abdominopelvic mass and symptoms due to pressure on adjacent organs.  
Leiomyomas are classified depending on the location in the corpus as submucosal 
(projecting  into  the  uterine  cavity),  intramural  (confined  to  the  myometrium)  and 
subserosal (projecting from the peritoneal surface of the uterus).  Submucosal fibroids, 
although less common, produce symptoms most frequently.  8% can occur in the cervix37. 
The size and the number of leiomyomas are variable.  Although little is known 
about the factors responsible for the initial neoplastic transformation, it is hypothesised 
that  each  leiomyoma  arise  from a  single  cell  in  myometrium.   Several  observations 
suggest that oestrogen and progesterone play an important role in growth of leiomyoma. 
 As leiomyoma enlarge, they may outgrow their blood supply, resulting in various 
types of degenerations namely hyaline,  myxoid, calcific, cystic and red degeneration
Leiomyomas present with variable appearances in sonography37.They are
1. Globular enlargement of uterus with heterogenous echotexture due to small 
diffuse leiomyomas.
2. Localized leiomyomas are hypoechoic or heterogenous echotexture with contour 
irregularity.
3. May have areas of acoustic attenuation or shadowing due to dense fibrosis within 
the tumour.
4. Calcification appears as focal areas of increased echogenicity with shadowing or 
as a curvilinear echogenic rim in periphery.
5. Cystic degeneration and necrosis occur centrally and produce areas of decreased 
echogenicity.
Transvaginal  ultrasound  is  used  for  better  delineation  of  small  fibroids, 
submucosal  fibroids  and  showing  the  uterine  origin  of  pedunculated  fibroids. 
Leiomyomas in the fundus of the retroverted uterus are much better delineated by 
transvaginal sonography.
Schwartz LB, Zawin M, Carcangiu ML, Lange R, McCarthy S, etal6 study on 
‘Does  pelvic  MRI  differentiate  among  the  histologic  subtypes  of  uterine 
leiomyomata?’, states MRI has 95% sensitivity and 72% specificity for diagnosing an 
uncomplicated  leiomyoma,  10%  sensitivity  and  100%  specificity  for  a  cellular 
leiomyoma, 80% sensitivity and 98% specificity for cystic leiomyomata and 100% 
sensitivity and 86% specificity for a haemorrhagic leiomyomata
Weinreb JC, Barkoff ND, Megibow A, Demopoulos R etal4 studied the value 
of MR imaging in distinguishing leiomyomas from other solid pelvic masses when 
sonogrphy  is  indeterminate  and  concluded  that  as  leiomyomas  often  have 
characteristic  MR  appearance  which  will  help  to  differentiate  from  other  pelvic 
masses, MRI is useful diagnostic tool in deciding on sonographically indeterminate 
masses. 
Togashik, Ozasa H, Konishi I, Itoh H, Nishimura K, Fujisawa J, Noma S, 
Sagoh T, Minami S, Yamashita K etal7 studied 93 patients with enlarged uterus in 
differentiating  between  adenomyosis  and  leiomyoma  with  MR  imaging  and 
concluded that MR imaging is highly accurate.  
Study done by Murase E etal18 and associate on histopathological features, MR 
imaging  findings,  differential  diagnosis  and  treatment  of  uterine  leiomyomas, 
observed that  on T2  weighted  images  non degenerated  leiomyoma  appear  as  well 
circumscribed  masses  of  decreased  signal  intensity  (SI).   However  cellular 
leiomyomas can have relatively higher SI on T2 weighted images and demonstrate 
enhancement on contrast images.  Degenerated leiomyomas have variable appearance 
on T2  weighted images and contrast enhanced images.  The differential diagnosis of 
leiomyoma includes adenomyosis, solid adnexal mass, focal myometrial contraction 
and uterine leiomyosarcoma.  
Another study done by  Hricak H etal17 and associates on uterine leiomyomas 
correlation  of  MR,  histopathological  findings  and  symptoms  states  hyaline, 
myxomatous,  fatty  degenerations  are  seen  in  MRI  as  various  degrees  of 
inhomogenicity.  This is better seen in long TR, TE sequences.  It was concluded that 
MR  is  an  accurate  modality  for  imaging  uterine  leiomyomas  since  it  clearly 
demonstrates  tumour  number,  size,  location  and  the  presence  and  extent  of 
degeneration.
Kim JC, Kim SS and Park JY etal20 studied the 'Bridging vascular sign' in the 
MR  diagnosis  of  exophytic  uterine  leiomyoma  in  26  patients.   It  is  defined  as 
presence of curvilinear tortuous signal void vascular structures crossing between the 
uterus and pelvic mass.  Only exophytic uterine leiomyoma has this sign.  So they 
concluded bridging vascular sign on MRI may be a useful radiological sign in the 
diagnosis and differentiation of an exophytic uterine leiomyoma from other masses 
arising in the adnexa.  
Kawakami S, Togashi K, Konishi J, Kimura I, Fukuoka M, Mori T, Konishi 
etal21 retrospectively studied the MR features useful in diagnosing red degeneration 
of  uterine  leiomyoma.   It  shows  hyperintense  rim  on  T1 weighted  images  and 
hypointense  rim on T2 weighted images.   These findings correspond to numerous 
dilated  vessels  filled  with  red blood cells  at  periphery of  the  lesion.   The signal 
characteristics  of the rim are best  explained as an effect  of abundant intracellular 
methaemoglobin in these vessels.  They concluded recognition of these characteristics 
may help the radiologist  to differentiate  symptomatic  red degeneration from other 
clinical conditions that need surgical intervention.
Some leiomyoma have a high signal intensity rim on T2 weighted images, which 
represents a pseudo capsule of dilated lymphatic vessels, dilated veins or oedema. 
These histologic findings shown to correspond to peritumoral  rim enhancement in 
contrast enhanced images.  
Burn  PR  etal52 and  associates  studied  uterine  fibroleiomyoma:  MR  imaging 
appearances before and after embolisation of uterine arteries.  MRI done before and at 2 
and 6 months of the embolisation of the uterine arteries.  Signal intensity of leiomyoma 
was  compared  to  skeletal  muscle.   Volume  and  enhancement  characteristics  were 
assessed.  Their  results showed reduction in volume was 43% at 2 months, 59% at 6 
months. Before embolisation high Signal intensity on T1 weighted images was predictive 
of poor response.  High Signal intensity on T2 was predictive of a good response.  The 
degree  of  gadolinium  enhancement  was  not  correlated  in  fibroleiomyoma  volume 
reduction.  Concluded that MRI characteristic of fibroleiomyomas before embolisation 
can help predict subsequent response to treatment.
Oguchi O etal54 and associates studied the correlation between T2 characteristics and 
effect  of  GnRH  analogue  therapy.   They  observed  with  increasing  Signal  intensity,  
leiomyoma show increased cellularity and proliferative activity and show more reduction 
in size with GnRH treatment.
ADENOMYOSIS
Adenomyosis is characterised by presence of ectopic endometrial glands and stroma 
within the myometrium, which are associated with reactive hypertrophy of surrounding 
myometrial smooth muscles36,37.  
Adenomyosis most likely results from direct invasion of the myometrium by basal 
endometrium.  They are resistant to hormonal stimulation and do not undergo the full 
cyclic  changes  of  normal  functional  endometrium.   In  contrast  in  endometriosis  the 
glands undergo the same cyclic change as the normal endometrium.  Adenomyosis is 
most commonly a diffuse abnormality but may also occur as a focal mass which is known 
as  an  adenomyoma.   The  clinical  presentation  may  include  dysmenorrhoea  and 
menorrhagia  a  presentation  similar  to  that  of  uterine  leiomyoma.   It  affects 
premenopausal multiparous women over the age of 30 years36,37,38.  
Transabdominal sonographically the diagnosis has been considered to be difficult37. 
It  can  be  suggested  if  there  is  diffuse  uterine  enlargement  with  normal  contour, 
thickening of posterior myometrium and tiny necrotic area in myometrium.  
Transvaginal  sonography  is  more  accurate  in  diagnosing  this  condition  than 
transabdominal ultrasound.  The criteria are37 
1. Inhomogenous  hypoechoic  areas  within  the  myometrium  having  indistinct 
margins.  
2. Small myometrial cyst representing dilated glands in ectopic endometrial tissue.
3. Localized  adenomyoma  appear  as  inhomogenous  circumscribed  areas  in 
myometrium having indistinct margins and containing anechoic lacunae.
Reinhold  C,  Atri  M,  Mehio  A,  Zakarian  R,  Aldis  AE,  Bret  PM  etal11 studied 
morphologic  criteria  and  diagnostic  accuracy  of  endovaginal  sonography  in  diffuse 
uterine adenomyosis.  Criteria are poorly defined area of abnormal echotexture (Increased 
or decreased echogenicity,  heterogenous echotexture,  myometrial  cyst).   Results  show 
sensitivity of 86% and specificity of 86%.  They concluded that adenomyosis of uterus 
could be accurately diagnosed with endovaginal  ultrasound with specific  sonographic 
criteria.
Byun JY, kim SE, Choi BG, Ko GY, Jung SE, Choi KH etal5 evaluated the MRI 
imaging finding in diffuse and focal adenomyosis in 45 patients. Characteristic of diffuse
adenomyosis is diffuse thickening of endometrial -  myometrial junctional zone (7 to 37 
mm,  mean  16 mm) with homogenous  low signal  intensity  in  T2 weighted  sequence. 
High signal intensity foci can be seen in T1/T2 weighted sequences or in both.
Characteristic of focal adenomyoma is localized low SI round or oval mass with 
diameter of 2-7 cm with ill defined margins with high signal intensity foci either in T2 
weighted sequences or in both T1 and T2 weighted sequences.  They concluded that MRI 
is useful in differentiating adenomyosis from uterine myoma and planning appropriate 
treatment.  
T2 weighted  imaging  provides  significantly  better  lesion  detection  than 
unenhanced or contrast enhanced T1weighted images.  The thickness of normal junctional 
zone changes during the menstrual cycle whereas the thickness of diffuse adenomyosis 
remains unchanged.  
High signal intensity foci within the low signal intensity lesion in T2 weighted 
images only represent endometrial tissue or cyst.  High signal intensity in both T1 and T2 
weighted  images  correspond  to  the  haemorrhage  within  the  endometrial  islands. 
Identification of punctate high signal intensity foci adds specificity to the diagnosis of 
adenomyosis.  It is seen in 40% cases of diffuse adenomyosis and 100% cases of focal 
adenomyosis5.
Ascher SM, Arnold LL, Patt  RH, Schruefer JJ,  Bagley AS,  Semelka RC, 
Zeman RK, Simon JA etal12 prospectively compared MRI with Transvaginal ultrasound 
in detection of adenomyosis in 20 women and concluded that MRI is significantly better 
(P< 0.02) than Transvaginal ultrasound.  
Sugi mura K, Okizuka H, Imaoka I, Kaji Y, Takahashik, Kitao M, Ishida T 
etal16 in their study of pelvic endometriosis detection and diagnosis with chemical shift 
MR  imaging  in  35  women  with  clinical  diagnosis  of  endometriosis  observed  that 
Fatsaturation T1 weighted imaging in combination with conventional technique accurately 
demonstrated the lesions.
The distinction between adenomyosis  and leiomyoma is of clinical importance 
because unlike leiomyomas which may be treated with myomectomy, adenomyosis can 
be  extirpated  only  with  hysterectomy.   The  importance  of  accurately  diagnosing 
adenomyosis preoperatively has been stressed in many articles5.  
ENDOMETRIAL POLYP
Endometrial polyps are benign nodular protrusions of the endometrial surface that 
consist of irregularly distributed endometrial glands and stroma.  They generally consist 
of three components.  
1. Stroma of focally or diffusely dense fibrous or smooth muscle tissue
2. Thick walled vessels 
3. Endometrial glands
Cystic glandular hyperplasia within the polyp occurs most commonly.  Ralf P etal22 
and associates in their study concluded central fibrous core (Low signal intensity in T2 
weighted images) and intratumoral cysts (High signal intensity on T2  weighted images) 
were  seen  most  frequently  in  endometrial  polyps  than  in  carcinomas.   Myometrial 
invasion and necrosis showed high predictive value for carcinomas.   Accuracy does not 
appear to be sufficient to obviate biopsy, partly because carcinoma and polyps frequently 
co-exist.  
On  ultrasound,  polyp  is  seen  as  focal  thickening  of  endometrium.   On 
hysterosonosalphingography  polyp  is  seen  as  homogenously  echogenic  lesion  with 
narrow base of attachment.   It  is  better  seen because of the surrounding fluid in  the 
endometrial  cavity.   Well  defined vascular  pedicle  can  be seen with colour  Doppler. 
Cystic areas may be seen within the polyp representing histologically dilated glands. 
ENDOMETRIAL CARCINOMA 
Endometrial  carcinoma  is  the  most  common  gynaecological  malignancy  in  the 
western  world.   75 to  80% occur  in  postmenopausal  women.   80% of  the  cases  are 
diagnosed in the early stages as they present with spotting37.
Lee EJ, Byun JY, Kim BS, Koong SG, Shinn KS etal8 studied the usefulness of T2 
weighted and gadolinium enhanced T1 weighted sequences in staging early endometrial 
carcinoma and concluded that T2 weighted imaging was more accurate in premenopausal 
patients  and  gadolinium  enhanced  T1weighted  imaging  was  more  accurate  in  post 
menopausal patients.  
Manfredi R, Mirk P, Maresca G, Margarite PA, Testa A, Zannoni GF, Giordano 
D, Scambia G, Marano P etal9 studied 37 patients with endometrial carcinoma for local 
regional staging of endometrial carcinoma with MRI and concluded MRI coupled with 
contrast  material  enhanced dynamic  MR imaging  is  highly accurate  in  local  regional 
staging of endometrial  carcinoma.   More challenging is  the assessment  of pelvic  and 
lumbo aortic lymphnodes. 
Utsunomiya D, Notsute S, Hayashida Y, Lawakatase F, Katabuchi H, Okamura 
H,  Awai K, Yamashita Y etal10 studied endometrial carcinoma in adenomyosis of 11 
patients  and  concluded  dynamic  contrast  T1 weighted  imaging  improves  accuracy  of 
staging by delineating superficial and deep myometrial invasion.
Staging of endometrial carcinoma – FIGO 
Stage 0 - Imaging not applicable 
Stage 1 - Tumour confined to the uterine corpus.
         1a - Confined to endometrium.
        1b - Invasion to inner half of myometrium.
       1c - Outer half of myometrium
Stage 2 - Tumour extends into cervix
         2a - Cervical stroma not involved.  Only glandular involvement
         2b - Cervical stroma invaded.
Stage 3a - Invades serosa / adnexa / positive peritoneal cytology 
         3b - Vaginal metastasis
         3c - Metastasis to the pelvic or para aortic lymphnodes
Stage 4a - Invades bladder, bowel mucosa or both
4b     -    Distant  metastasis  including  intra  abdominal  and  inguinal 
lymphnodes. 
 Tsuada H etal24 in his comparative study of myometrial invasion detection by 
MRI and intrauterine ultrasound concluded that accuracy of both is 85%.  This is because 
in  two  cases  intrauterine  ultrasound  was  able  to  demonstrate  superficial  myometrial 
invasion that could not be diagnosed by MRI.  In contrast, intrauterine ultrasound was 
unable to diagnose myometrial invasion in two cases in which MRI could diagnose it.  
Veda M etal25 and  associates  retrospectively  analysed  8 cases  of  endometrial 
stromal sarcoma for MR characteristics and concluded irregular margin, nodular lesion at 
the  margin,  intra  myometrial  nodular  extension  and multiple  nodular  formation  were 
more  frequently  seen  in  cases  of  endometrial  stromal  sarcoma  than  in  cases  of 
endometrial  carcinoma.   MRI plays  a  role  in  diagnosing as  well  as in differentiating 
endometrial stromal sarcoma from endometrial carcinoma.  
Hricak H etal26 and associates study on MR evaluation of endometrial carcinoma 
results of an NCI Cooperative study states that overall accuracy with MR imaging for 
staging endometrial carcinoma was 85% MR is more useful in detection of myometrial 
invasion.   Intact  junctional  zone  implies  stage  1a.   An  irregular  interface  between 
endometrium and myometrial junctional zone or involvement of junctional zone is stage 
1b.  More than 50% myometrial involvement is 1c.
Tang X etal51 and associates study on Endometrial – Myometrium ratio, a newly 
proposed  diagnostic  parameter  on  MRI  assessment  of  myometrial  invasion  by 
endometrial carcinoma, defines that the myometrial invasion is present if the Endometrial 
Myometrial ratio is >1 and it is limited to Endometrium for values <1.
Brown JJ, Thurnher S, Hercak H etal29   in their retrospective study on MR 
Imaging  of  the  uterus:  low  signal  intensity  abnormalities  of  endometrium  and 
endometrial  cavity,  classified  the  causes  of  low  signal  intensity  as  submucosal 
leiomyoma,  blood clot,   endometrial  carcinoma, early intrauterine pregnancy,  retained 
products of conception and endometrial hamartoma.  Correct diagnosis was made only in 
9 of the 11 submucosal leiomyomas.  MR findings were non specific in remainder of 
cases.  Final conclusion was correlation with clinical history is essential and a specific 
diagnosis is not possible.
NABOTHIAN CYST CERVIX
Nabothian cysts  are  deep seated  retention  cysts  of  cervical  glands which may 
cause only minor surface irregularity.  Infection is a classic feature in the history of such 
patients.  Histologically it is an aggregation of cystic clefts, but the individual epithelial 
cells are benign.  The process is probably the result of occlusion of many channels by a 
non inflammatory, non neoplastic process36,37.
It  is  seen  in  ultrasound  as  tiny  anechoic  lesion  with  posterior  acoustic 
enhancement.  In MRI it is seen as hyper intense cysts in T2 weighted images.  
Li H,  Sugimura K,  Okizuka H,  Yoshida M,  Maruyama R,  Takahashi  K, 
Miyazaki K  etal15 studied marked high signal intensity lesions in uterine cervix on T2 
weighted  imaging  differentiation  between  mucin  producing  carcinoma  and  nabothian 
cysts as both will show high signal in T2 weighted images.  Malignancy to be considered 
in  gadolinium enhanced T1 weighted  images  if  there  is  1.  an  enhanced  lesion,  2.  an 
irregular margin, 3. iso intensity on T1weighted images.  In contrast, high signal intensity 
in T1 is considered benign.  So gadolinium enhanced T1 weighted imaging improves the 
specificity. 
CARCINOMA CERVIX:
Carcinoma  cervix  is  the  commonest  genital  malignancy  of  women  in  India. 
Second most common gynaecological malignancy in women in United States.  Cervical 
intra epithelial neoplasia is considered a precursor lesion of cervical cancer.  Carcinoma 
arises at squamocolumnar junction. In young women it grows predominantly exophytic 
and large parts of the tumour extends inferiorly into the vagina.  In older women with 
atrophic  cervices  the  squamo columnar  junction  is  located  in  endocervical  canal.   It 
involves supra vaginal portion of cervix and frequently extends laterally through cervical 
wall.    Two main histological types can be differentiated.  1. squamous cell carcinoma 
and 2. adenocarcinoma which carries worst prognosis.  
FIGO staging cervical carcinoma
Stage I - Limited to Uterus 
      IA - Pre clinical invasive carcinoma
      IA1 - Depth < 3mm, horizontal spread < 7mm
      IA2 - Depth 3 to 5 mm, horizontal spread < 7mm
     1B - Tumor greater than 1A2
Stage II - Beyond uterus but not to pelvic sidewall or lower third of 
vagina
         IIA - No parametrial invasion.
          IIB - With parametrial invasion
Stage III - Extends to pelvic wall / involves lower third of vagina / 
hydronephrosis
          IIIA - Lower third of vagina involved, not to pelvic sidewall 
IIIB - Pelvic side wall / hydronephrosis
Stage IV A - Tumour invades bladder mucosa or rectum /extends beyond 
true pelvis
IVB - Distant metastasis including lymph nodes beyond true 
pelvis
On ultrasound, carcinoma cervix is seen as solid irregular mass in the cervix.  It 
can be associated with haematometra or pyometra.  On MRI, cervical carcinoma appears 
as high signal intensity lesion than cervical stroma in T2 weighted images because it has 
longer T2 values than stroma.  
Chung JJ, Kim MJ, Cho NH, Park S, Lee JT, Yoo HS etal13 compared the T2 
weighted fast spin echo MR findings of adenocarcinoma of uterine cervix with squamous 
cell carcinoma and concluded that in T2 FSE the signal intensity ratio of tumour more 
than 3 can be considered as adenocarcinoma.  That is signal intensity of adenocarcinoma 
is higher than that of squamous cell carcinoma because multiple tumorous glands with 
cytoplasmic and intraglandular mucin / serous fluid were pathologically found in adeno 
carcinoma.   But  squamous  cell  carcinoma  revealed  compact  cellularity  of  stratified 
squamous tumour cells.   
Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JZ etal14 
studied invasive cervical carcinoma comparison of MR imaging and surgical findings and 
concluded that the overall accuracy of MR imaging in staging was 81%.  MR imaging is 
valuable because it can accurately demonstrate tumour location, tumour size, degree of 
stromal penetration and lower uterine segment involvement and ruling out parametrial 
pelvic sidewall, bladder and rectal involvement. 
Kims H, Han MC etal53 in their study on invasion of urinary bladder by cancer 
cervix evaluation with MRI considered the following findings as suggestive of vesical 
invasion.  They were 1) Nodularity and irregularity of bladder wall, 2) masses protruding 
into bladder lumen, 3) High Signal intensity of anterior aspect of posterior wall of the 
bladder and 4) Abnormal soft tissue strands in the uterovesical space.
To  identify  all  the  above  lesions  in  our  institution  we  use  T1 weighted  FSE 
sagittal,  T2weighted   FSE  in  two  planes  (sagittal,  either  oblique  coronal  or  oblique 
axial),Contrast  enhanced  T1 weighted  images  for  staging  malignant  lesions,  chemical 
shift imaging in cases of haemorrhagic cysts & dermoid ovary &optional sequence of 
GRE & Fat sat T2 in cases of haematometrocolpos. This is emphasized by the following 
studies.
Asher SM, O’malley J, Semelka RC, Patt RH, Rajan S, Thomasson D, etal1 
compared  FSE sequence  with  BHFSE in  32  women  for  imaging  characteristics  like 
quality, anatomy definition, lesion detection, free fluid detection and concluded that all 
pathology detected with T2 FSE was detected on BH T2  FSE despite the inherently poor 
spatial resolution of BH sequences compared with the non BH sequences.  
Thurnher SA etal2 studied the value of contrast enhanced MR images with that 
of T2 weighted MR images in the diagnosis and staging of pelvic masses in women and 
concluded  sensitivity  of  contrast  enhanced  MR  images  was  96%,  equal  to  that  of 
unenhanced T2  weighted  images  97% in  depiction  of  pelvic  lesions.   It  is  helpful  in 
detecting parametrial  invasion if T2 images are equivocal in cancer cervix and overall 
staging accuracy on contrast enhanced imaging was 80%. It was inferior to that of T2 
weighted imaging in which the staging accuracy was 83%.  Administration of contrast 
was not helpful in evaluation of subserous myoma.  He has also emphasised that contrast 
enhanced MR can be used as complementary sequence to T2 weighted sequence  
1. To predict malignancy in adnexal tumours
2. To stage endometrial carcinoma.
3. To determine tumour extension in cancer cervix.
Hricak  H,  Finck  S,  Honda  G,  Gorahson  H  etal3 studied  the  value  of 
gadopentate dimeglumine enhanced T1 weighted images in evaluation of benign uterine 
masses  and  concluded  with  conventional  spinecho  sequences  the  use  of  contrast 
enhanced  T1 weighted  images  does  not  improve  the  detection  or  characterisation  of 
uterine  leiomyomas  or  adenomyosis,  but  significantly  improves  the  detection  of 
endometrial polyps.    
 
                    
MATERIALS AND METHODS
A prospective study of 52 patients with suspected uterine masses referred from 
Institute  of  Obstetrics  and  Gynaecology  department,  Egmore  was  done  in  Barnard 
Institute of Radiology, Madras Medical College from July 2004 to August 2005.
All  patients  were  subjected  to  Transabdominal  Ultrasound,  Transvaginal 
Ultrasound  and  MRI  examination.  Then  depending  upon  the  final  diagnosis  they 
underwent endometrial curettage, cervical biopsy, myomectomy or hysterectomy. Final 
histopathological report was taken as gold standard to compare the findings and the final 
diagnosis of each imaging modality.
 Grey scale Transabdominal and Transvaginal Ultrasound were performed using a 
3500 series Aloka unit; equipped with 3.5 mega hertz convex probe and 5.0 mega hertz 
Transvaginal  probe.  MRI  was  performed  using  Siemens  1.5  tesla  superconducting 
Magnetome using CP spine array coil.
METHOD
A preliminary abdominal examination, per speculum and per vaginal examination 
was done. Transabdominal Ultrasound was done in full bladder with optimal settings, 
then  bladder  emptied  and  Transvaginal  Ultrasound  done.  In  both  the  Ultrasound 
examinations the following uterine parameters were noted: the size of the uterus, contour 
–  regular/  lobulated,  endometrium  –  homogenous  /  inhomogenous,  echogenic  / 
hypoechoic  comparing  to  the  myometrium,  endometrial  thickness  –  measured  from 
myometrial  –  endometrial  junction  (  outer  echogenic  layer)  to  the  opposite 
myoendometrial junction.                                            
Presence  or  absence  of  endometrial  cavity  fluid,  any  mass  lesion  within  the 
endometrium, if mass present single or multiple and its characteristics were noted.
   In the myometrium homogenous/ inhomogenous echotexture, anterior and posterior 
wall  symmetry/asymmetry,  presence  of  any  myoma,  if  so  location  like  submucous, 
intramural  and  subserosal,  number  of  lesions,  echogenicity  of  the  lesions,  areas  of 
calcification, cystic change within the lesion and shadowing were noted.
 Presence of any cyst within the myometrium, if so single or multiple and location 
like anterior or posterior myometrium were noted. 
Is the lesion causing indentation on the bladder wall, whether the cervix is normal or 
abnormal, if abnormal is there nabothian cyst, polyps, mass, if mass the extension of the 
mass and associated any endometrial collection were seen. 
Bilateral adnexa to visualize ovary whether normal or abnormal, if so any mass or 
cystic lesions were also noted. Other routine screening of abdominal organs was done and 
any  positive  findings  were  noted  for  presence  of  hydronephrosis,  ascites  and 
lymphadenopathy. 
MRI PELVIS
              Patient was placed in supine position in MR gantry.
Technique used 
  A scout coronal section was obtained to plan for sagittal views. Oblique coronal 
and oblique axial sections were planned using sagittal slices ( along the axis of uterus 
and perpendicular to it ) .
The sequences used were 
a. T1 weighted sagittal
 TR 700ms                                   TE   10ms
 Number of slices 22                                       Slice thickness 4mm
 FOV     300                                                     Matrix size 256x256 
b. T2 weighted sagittal, coronal and axial 
         TR   3250ms                                                  TE 97 ms
         Number of slices   22                                      Slice thickness 4mm
         FOV 300                                                         Matrix size 256x256
Optional Sequences
Fat Saturation in cases of Endometriosis and Ovarian dermoid 
MRI EVALUATION
In  addition  to  the  findings  noted  in  the  Ultrasonogram,  in  MRI the  maximal 
junctional zone thickness was measured and junctional zone to myometrial thickness 
ratio calculated. For this, single layer of junctional zone is measured at the level of 
maximum thickness and the myometrial thickness is measured at the same level.
Intensity of the lesions in both T1 and T2 weighted images were noted. Number 
and location of the lesions were also noted. In case of endometrial lesions, level of 
myometrial  invasion and in cases of Carcinoma Cervix,  extent  of the lesions was 
noted. 
INCLUSION CRITERIA
All  patients  referred  from  Institute  of  Obstetrics  and  Gynaecology,  Egmore 
suspected to have uterine mass lesions willing to undergo all three tests and willing 
for surgery   were included in the study. 
EXCLUSION CRITERIA
Patients who did not undergo all three tests.
Not operated or non availability of the histopathological examination report.
Patient with MR incompatible devices or implants.
Patients with Claustrophobia.
This study confines to the ethics and was done with the consent and full 
co-operation of the patient.
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RESULTS AND ANALYSIS
The  ability  of  MRI,  Transabdominal  ultrasound  and  Transvaginal  ultrasound  to 
characterize  and diagnose the uterine mass lesions were compared with histopathological  
findings and were analysed, using various statistical tests.  MR characteristics of each lesion  
were also evaluated.  
The  final  histopathological  findings  after  hysterectomy,  myomectomy,  fractional 
curettage,  cervical  biopsy  were  accepted  as  the  reference  standard  against  which  the  
Transabdominal  ultrasound,  Transvaginal  ultrasound  and  MRI  imaging  findings  were 
compared.  
Diagonal  agreement,  Cohen’s  Kappa,  Z  value  are  calculated  comparing  two 
modalities like Transabdominal  USG – MRI,  Transvaginal  USG – MRI,  Transabdominal  
USG – Trans vaginal USG in detecting mass lesions in the uterus.  Percentage of diagonal 
agreement implies number of cases detected as same final outcome regarding the presence of  
mass in both the modalities.  
Sensitivity,  specificity,  correctclassification,  misclassification,  Kappa  values 
calculated for  each  modality  for  all  cases coming under  each  final  diagnosis  and  finally 
compared.  
Correctclassification  is  concordance  between  the  diagnosis  by  that  particular 
modality and HPE.  Misclassification is discordance between the diagnosis by a modality and 
HPE.  Cohen’s Kappa is used to compare the correlation between the modalities. The values 
of Kappa were classified as 0.0-0.2 no correlation, 0.2-0.4 fair correlation, 0.4-0.6 moderate  
correlation, 0.6-0.8 good correlation, 0.8-1.0 very good correlation.  
DISTRIBUTION OF PATIENTS IN RELATION TO AGE
Age of 
patients
No of 
patients Percent
<40 32 61.5
41-50 8 15.4
51-60 8 15.4
>60 4 7.7
Total 52 100.0
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DISTRIBUTION OF CASES AS PER FINAL DIAGNOSIS
DIAGNOSIS NO OF CASES
ADENOMYOSIS 12
FIBROID 24
CA CERVIX 10
CA ENDOMETRIUM 3
ENDOMETRIAL POLYP 2
NORMAL 1
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Distribution of cases as per final diagnosis
No.of cases
FINAL DIAGNOSIS Mean Age
Adenomyosis 33.67
Fibroid 39.83
Endometrial Ca 54.50
Ca cervix 56.60
Cervical polyp 35.00
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COMPARISON OF MODALITIES IN MYOMETRIAL MASS DETECTION
MYOMETRIAL MASS TRANSABDOMINAL, TV USG CROSSTABULATION
TV USG MASS
Total
mass 
absent
ill 
defined present
USG 
MASS
mass 
absent 18 2 1 21
ill 
defined 1 2 9 12
present 0 0 19 19
Total 19 4 29 52
DIAGONAL AGREEMENT   ; 75%
COHEN`S KAPPA    ( K )        ; 0.6
 Z      ; 6.16
                                            P     <   0.01
MYOMETRIAL MASS TRANSABDOMINAL USG, MRI CROSSTABULATION
MRI MASS
Total
mass 
absent
ill 
defined present
USG 
MASS
mass 
absent 17 3 1 21
ill 
defined 1 1 10 12
present 0 0 19 19
Total 18 4 30 52
DIAGONAL AGREEMENT   ; 71%
COHEN`S KAPPA    ( K )        ; 0.54
                                         Z         ; 5.6
                                         P         <  0.01
MYOMERIAL MASS TRANSVAGINAL USG, MRI CROSSTABULATION
 
MRI MASS Total
mass 
absent
ill 
defined present  
TRANS 
VAGINAL 
USG 
MASS
 
 
mass 
absent 18 1 0 19
ill 
defined 0 3 1 4
present 0 0 29 29
Total 18 4 30 52
DIAGONAL AGREEMENT   ;  96%
COHEN`S KAPPA    ( K )     ; 0.93
                                    Z        ; 8.09
                                     P      <  0.01
CATEGORISING  MYOMETRIAL MASS TRANSABDOMINAL USG, MRI  
CROSSTABULATION
 
 
MRI 
         
Total
submucosal
intramura
l subsero
subsero+
intramur submuco+intramur+subsero  
US
G 
 
 
submuco 0 0 0 0 0 0
intramura
l 5 6 0 0 0 11
subsero 0 1 1 0 0 2
subsero+
intramur 0 0 0 6 5 11
Total 5 7 1 6 5 24
DIAGONAL AGREEMENT  ;   54%
COHEN`S KAPPA    ( K )    ; 0.38
                                    Z       ; 3.89
                                     P     <  0.01
CATEGORISING MYOMETRIAL MASS TRANSVAGINAL USG, MRI  
CROSSTABULATION
 
MRI Total
submucosal
intramura
l subsero
subsero+
intramur submuco+intramur+subsero  
TV 
USG
 
 
 
submuco 2 0 0 0 0 2
intramu 3 7 0 0 0 10
subsero 0 0 1 0 0 1
subsero+
intramur 0 0 0 6 5 11
Total 5 7 1 6 5 24
DIAGONAL AGREEMENT   ; 67%
COHEN`S KAPPA    ( K )     ; 0.55
                                    Z        ; 5.24
                                     P      <  0.01
ADENOMYOSIS DETECTION TRANSABDOMINAL USG
TRANS 
ABDOMINAL
ULTRASOUND
HPE
PRESENT ABSENT TOTAL
PRESENT 4 0 4
ABSENT 8 0 8
TOTAL 12 0 12
SENSITIVITY : 33% (9% - 65%) 
SPECIFICITY : 0%   
CORRECT CLASSIFICATION : 33% (9% - 65%)
MISCLASSIFICATION : 67% (34%-94%)
KAPPA : 0 (poor agreement)       
ADENOMYOSIS DETECTION TRANSVAGINAL USG
TRANS 
VAGINAL 
ULTRASOUND
HPE
PRESENT ABSENT TOTAL
PRESENT 7 0 7
ABSENT 5 0 5
TOTAL 12 0 12
SENSITIVITY : 58% (28% - 85%) 
SPECIFICITY : 0%   
CORRECT CLASSIFICATION : 58% (28% - 85%)
MISCLASSIFICATION :42% (15%-82%)
KAPPA : 0 (poor agreement)  
    
ADENOMYOSIS DETECTION MRI
MRI
HPE
PRESENT ABSENT TOTAL
PRESENT 11 1 12
ABSENT 0 0 0
TOTAL 11 1 12
SENSITIVITY : 92% (62% -100%) 
SPECIFICITY : 0%   
CORRECT CLASSIFICATION : 92% (62% -100%)
MISCLASSIFICATION :8% (0%-45%)
KAPPA : 0 (poor agreement)        
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ADENOMYOSIS DETECTION 
SENSITIVITY COMPARISON
TYPES OF ADENOMYOSIS NO OF CASES
FOCAL 2
DIFFUSE 10
TYPES OF ADENOMYOSIS
2
10
FOCAL
DIFFUSE
DETECTION OF FIBROID BY TRANSABDOMINAL USG AMONG TOTAL 
CASES
TRANS 
ABDOMINAL 
USG
HPE
 PRESENT ABSENT TOTAL
PRESENT 19 4 23
ABSENT 5 24 29
TOTAL 24 28 52
SENSITIVITY : 79% (58% - 93%) 
SPECIFICITY : 86% (67% - 96%)  
CORRECT CLASSIFICATION : 83% (70% -92%)
MISCLASSIFICATION :17% (8%-32%)
KAPPA : 0.65 (Good)
  P   <   0.01
DETECTION OF FIBROID BY TRANSVAGINAL USG AMONG TOTAL CASES
TRANS 
VAGINAL 
USG
HPE
 PRESENT ABSENT TOTAL
PRESENT 24 3 27
ABSENT 0 25 25
TOTAL 24 28 52
SENSITIVITY :100% (86% -100%) 
SPECIFICITY : 89% (72% - 98%)
CORRECT CLASSIFICATION : 94% (84% -99%)
MISCLASSIFICATION : 6% (1%-7%)
KAPPA : 0.89 (Very good)
     P   <   0.01
DETECTION OF FIBROID BY MRI AMONG TOTAL CASES
MRI
HPE
 PRESENT ABSENT TOTAL
PRESENT 24 1 25
ABSENT 0 27 27
TOTAL 24 28 52
SENSITIVITY :100% (85% -100%) 
SPECIFICITY : 96% (82% -100%)
CORRECT CLASSIFICATION : 98% (90% -100%)
MISCLASSIFICATION :2% (0%-7%)
KAPPA : 0.96 (Very good)
     P   <   0.01
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FIBROID DETECTION SENSITIVITY COMPARISON
DIFFERENTIATION BETWEEN ADENOMYOSIS AND FIBROID BY
TRANSABDOMTNAL USG
TRANS 
AB
DO
MI
NA
L
USG 
HPE
 ADENOMYOSIS FIBROID TOTAL
ADENOMYOSIS 4 13 17
FIBROID 8 11 19
TOTAL 12 24 36
SENSITIVITY  :33% (10% -65%) 
SPECIFICITY  : 46% (26% -67%)  
CORRECT CLASSIFICATION  : 42% (26% -59%)
MISCLASSIFICATION  : 58% (41%-69%)
POSITIVE PREDICTIVE VALUE    : 24%(7%-50%)
NEGATIVE PREDICTIVE VALUE : 58%(34%-80%)
FALSE POSITIVE RATE  : 54%(33%-74%)
FALSE NEGATIVE RATE  : 67%(34%-90%)
KAPPA  : 0.19 (Poor)
  P   >   0.05
           MC NEMAR`S  TEST         X2   1.19 P =0.38  (Not  significant)
DIFFERENTIATION BETWEEN ADENOMYOSIS AND FIBROID BY 
TRANSVAGINAL USG
TRANS 
VAGINAL
USG 
HPE
 ADENOMYOSIS FIBROID TOTAL
ADENOMYOSIS 7 2 9
FIBROID 5 22 27
TOTAL 12 24 36
SENSITIVITY : 58% (28% -84%) 
SPECIFICITY : 92% (73% -99%)  
CORRECT CLASSIFICATION : 81% (64% -92%)
MISCLASSIFICATION : 19% (18%-42%)
POSITIVE PREDICTIVE VALUE   : 78%(40%-97%)
NEGATIVE PREDICTIVE VALUE : 82%(62%-94%)
FALSE POSITIVE RATE  : 8%(1%-27%)
FALSE NEGATIVE RATE  : 42%(15%-72%)
KAPPA  : 0.53 (Moderate)
 P           < 0.01
             MC NEMAR`S  TEST   X2   1.29 P =0.45  (Significant)
DIFFERENTIATION BETWEEN ADENOMYOSIS AND FIBROID BY MRI
MRI 
HPE
 ADENOMYOSIS FIBROID TOTAL
ADENOMYOSIS 11 0 11
FIBROID 1 24 25
TOTAL 12 24 36
SENSITIVITY : 92% (62% -100%) 
SPECIFICITY : 100% (86% -100%)  
CORRECT CLASSIFICATION : 97% (86% -100%)
MISCLASSIFICATION : 3% (0%-18%)
POSITIVE PREDICTIVE VALUE   : 100%(72%-100%)
NEGATIVE PREDICTIVE VALUE  : 96%(80%-100%)
FALSE POSITIVE RATE  : 0%(0%-14%)
FALSE NEGATIVE RATE  : 8%(0%-38%)
KAPPA  : 0.93 (Perfect)
 P   <   0.001
            MC NEMAR`S TEST    X2   1. P  =0.31 (Significant)
DETECTION OF ENDOMETRIAL CARCINOMA BY MRI AND TV USG AMONG 
TOTAL CASES
TV USG 
A
N
D
M
R
I
HPE
 PRESENT ABSENT TOTAL
PRESENT 3 1 4
ABSENT 0 48 48
TOTAL 3 49 52
SENSITIVITY :100% (29% -100%) 
SPECIFICITY : 97% (89% -100%)  
CORRECT CLASSIFICATION : 97% (89% -100%)
MISCLASSIFICATION :3% (0%-7%)
KAPPA : 0.85 (Very good)
        P   <   0.01
DETECTION OF NABOTHIAN CYST COMPARISON BETWEEN 
TRANSABDOMINAL USG AND MRI
TRANS 
AB
DO
MI
NA
L 
US
G
MRI
 PRESENT ABSENT TOTAL
PRESENT 1 1 2
ABSENT 8 0 8
TOTAL 9 1 10
SENSITIVITY :11% (0% -48%) 
SPECIFICITY : 0%  
CORRECT CLASSIFICATION : 10% (0% -45%)
MISCLASSIFICATION :90% (55%-100%)
KAPPA : 0.21 (Fair agreement) 
        P   <   0.01
DETECTION OF NABOTHIAN CYST COMPARISON BETWEEN TRANS 
AGINAL USG AND MRI
TRANS 
V
A
G
I
N
A
L 
U
S
G
MRI
 PRESENT ABSENT TOTAL
PRESENT 5 1 6
ABSENT 4 0 4
TOTAL 9 1 10
SENSITIVITY :56% (21% -86%) 
SPECIFICITY : 0%  
CORRECT CLASSIFICATION : 50% (19% -81%)
MISCLASSIFICATION :50% (81%-86%)
KAPPA : 0.19 (Fair agreement) 
        P   <   0.01
DISCUSSION
Transabdominal USG, transvaginal USG and MRI were performed on 52 patients 
who were referred from the Institute of Obstetrics and Gynaecology for evaluation of 
uterine mass lesions.  Depending upon the final diagnosis they underwent myomectomy, 
hysterectomy,  endometrial  curettage or cervical  biopsy.   The patients were in the age 
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group ranging from 30 to 65 yrs.  32 patients in 30 to 40 yrs, 8 in 40 to 50 yrs, 8 in 50 to 
60 yrs and 4 over 60 yrs, with the mean age of 42.5 yrs.
68% of the patients were in the premenopausal age group, 33% of the patients 
were in the postmenopausal age group.  In our study most of the patients were in the 
reproductive age group.  This is because benign mass lesions are more commonly seen in 
this age group.
This is emphasized by  VG Padubidri, Shirish N Daftary, etal38  .  Out of 52 
patients in our study, 36 patients (69.2%) presented with complaints of pain, 19 (37%) 
patients had bleeding, 3 patients (6%) had mass felt by themselves, 16 patients (31%) had 
discharge  PV,  1  patient  (1.9%)  with  loss  of  weight,  3  patients  (5.8%)  with  loss  of 
appetite.  Few had more than one complaint. But the common presentations were pain 
abdomen, bleeding PV and discharge PV.
Among  the  total  52  patients,  all  were  married  except  2  (3.8%).   Among  the 
married patients, all had more than one child except 5 (9.6%) who had infertility.  Among 
the total 52 patients 29% had permanent sterilization.  In the remaining 71%, 20% of the 
patients were practicing temporary contraception. 
Among  the  premenopausal  patients,  33% presented  in  the  proliferative  phase, 
33% in the secretory phase.  Among the total patients 21% had increased flow, 7% had 
increased flow with clots during menstruation, 46% had dysmenorrhoea. 
The total patients were subgrouped into 5 depending upon the histopathological 
diagnosis. Adenomyosis –12 patients;  Fibroid –24 patients; Endometrial carcinoma –3 
patients,  Carcinoma  cervix  -10patients,  Cervical  polyp  -2  patients.   Among  the  total 
patients 17 had adnexal lesions, 4 patients had mass lesions and 13 had cysts. Among 13 
patients with cysts, one patient had endometriotic cyst.  Sensitivity and specificity were 
calculated for each modality in each subgroup and compared.
First  in  detection  of  myometrial  mass  lesions,  3  sets  of  data  are  derived  by 
comparing two modalities in each.  When comparing transabdominal USG and MRI in 
myometrial mass lesion detection the diagonal agreement was 71%.  It means only 71% 
of the mass lesions seen in MRI is seen in the USG. Diagonal agreement between the 
transvaginal  USG and MRI is  96%. Diagonal  agreement  between the transabdominal 
USG and transvaginal USG is 75%.
In classifying myometrial mass lesions, the diagonal agreement between USG and 
MRI is 54%, between transvaginal USG and MRI is 67%.  This is because sub mucosal  
lesion  detection  is  zero  with  transabdominal  USG and  only  two  submucosal  lesions 
among 6 were diagnosed in transvaginal USG.  But all are seen in MRI.
Localizing the site of lesion and number of lesions is best with MRI.  It gives 
visual picture to the surgeon.  All infertile women going for uterine preservation surgery 
should undergo MRI before planning the surgical procedure. 
Among fibroids 2, 4, 5 patients showed cystic degeneration with transabdominal 
ultrasound,  transvaginal  ultrasound  and  MRI  respectively.9,10,4  patients  show 
calcification in transabdominal ultrasound, transvaginal ultrasound and MRI respectively.
Among  total  52  cases,  the  sensitivity  of  USG  in  detecting  fibroid  is  79%, 
specificity is 86%, and kappa is 0.65 (adequate), P < 0.01 stating that it is statistically 
significant.  
Tranvaginal ultrasound in detecting fibroid the sensitivity is 100%, specificity is 
89%, and kappa is 0.89, P< 0.01.  In MRI the sensitivity is 100%, specificity is 96%. 
This is because in MRI one case reported as having both adenomyosis and fibroid turned 
out to be a focal adenomyoma with diffuse adenomyosis.  No fibroid was found. In USG 
many intramural lesions of adenomyosis are reported as fibroid reducing the specificity. 
Duiak CM, Turner DA, Patel SK, Archie JT, Silver B, Norusis M etal39 on 
their  study on uterine  leiomyomas  in  the  infertile  patient  on 11 women  reported  the 
sensitivity  of  MRI  as  85%,  accuracy  94% is  better  than  the  USG (Transabdominal) 
sensitivity 69%, accuracy 87%.  The specificity of the modalities did not significantly 
differ and concluded that MR imaging is superior to USG or HSG for preoperatively 
locating leiomyomas.  This study correlates with the findings of our study with the USG 
sensitivity of 79% and MR sensitivity of 100%.
Zawin M, Mc carthy S, Scout LM, Comite F et al40 studied  high-field MRI and 
USG evaluation of pelvis in women with leiomyomas of 23 women.  They have observed 
accurate  determination  of uterine  volume was possible  in  all  cases  by MRI,  but  was 
limited  on  USG  in  uterus  larger  than  140  cc.   Marked  enlargement  obscured  the 
visualization of contour abnormalities in USG.  Endometrial stripe and junctional zone 
could not be adequately visualised in 21 out of 23 ultrasound examinations.  MRI detects 
more submucosal (14) lesions and concluded that MRI is superior to the ultrasound in 
pelvic examination of women with leiomyoma.  This correlates with our study in which 
transabdominal ultrasound did not detect any submucosal lesions.  Transvaginal detected 
two out of 6 lesions and MRI detected all 6 lesions.  
Among 12 patients  who had adenomyosis  histopathologically  10 of  them had 
pain,  5  patients  had  bleeding  PV,  5  patients  had  both,  4  had  discharge  PV. 
Dysmenorrhoea was present in 10 of them.1 patient had infertility. All patients were in 
the age group of 31-39 years. This fits in with the VG Padubidri, Shirish N Daftary et 
al38  report  that adenomyosis is usually seen in parous women around the age of 40 who 
present with menorrhagia and progressively increasing dysmenorrhoea. Pelvic discomfort 
and dyspareunia are the other symptoms of adenomyosis.
In the transabdominal ultrasound 8 of them had inhomogenous myometrial echo. 
11 of them had myometrial inhomogeneity in transvaginal scan.  7 patients had anterior, 
posterior  wall  myometrial  asymmetry  in  both  transabdominal  and  transvaginal 
ultrasound.   4  patients  had suspicious  intramural  hypoechoic  lesion in  the abdominal 
scan.  They were taken as positive for adenomyosis by transabdominal ultrasound.  
All 7 patients had posterior wall myometrial cyst.  3 of them had both anterior and 
posterior wall cyst in transvaginal scan.  
In MRI among 12 positive cases all had ill defined mass in the myometrium.  All 
patients had altered signal intensities in the myometrium.  3 of them had hyperintense 
signal in  both T1 and T2 weighted sequences suggestive of haemorrhagic endometrial 
glands.  In the rest 9, 4 of them had hyperintense signals in T2 weighted sequences and 5 
patients had hypointense areas which were ill defined in T2 weighted sequences. 
All patients had junctional zone above 10 mm with junctional zone myometrial 
ratio  of  above  23  in  positive  cases  of  adenomyosis.   In  one  patient  who  had  focal 
adenomyosis  the  junctional  zone  thickness  was  9  mm.   Among  12  total  patients  of 
adenomyosis one patient had fibroid and adenomyosis, 9 had diffuse adenomyosis, 2 had 
focal adenomyoma.
Among  12  positive  cases  of  adenomyosis  comparing  to  histopthological 
examination, sensitivity of transabdominal ultrasound is 33% in detecting adenomyosis. 
Kappa is 0 suggestive of poor agreement.  Sensitivity of transvaginal ultrasound is 58% 
kappa is 0 suggestive of poor agreement.  Sensitivity of MRI is 92% kappa showed poor 
agreement.   This  is  because we have taken only positive cases  of  adenomyosis.   No 
normal cases were sent for imaging.  Specificity cannot be calculated when only positive 
cases were taken into account.  But among three modalities MRI is more sensitive in 
detecting  adenomyosis.   Even  then  the  sensitivity  is  only  92%  because  one  case 
considered as fibroid by MRI turned out to be focal adenomyoma with normal junctional 
zone thickness.  
In  differentiating  between  adenomyosis  and  fibroid,  specificity  of 
Transabdominal  ultrasound,  Transvaginal  ultrasound and MRI in our study  inturn  is 
46%,92%,100%.Positive predictive value is 24%,78%,100%.Negative predictive value is 
58%,82%,96% and False positive rate is 58%,8%,and 0%.
Kang S, Turner DA et al41 study on  Adenomyosis: specificity of 5mm as the 
maximum normal uterine JZ thickness in MR images concluded that if a diagnosis of 
adenomyosis is based solely on junctional zone thickness in MR images, 5mm should not 
be assumed as upper limit of normal.  Because this assumption may result in a high false 
positive rate. Our study has showed 10 mm as minimal JZ thickness which goes by the 
norms of the above study. 
Phillips etal42 study on 20 patients confirmed MRI diagnosis of adenomyomata 
by  transabdominal  uterine  biopsy  or  by  resectoscopic  endometrial  biopsy  in  all  20 
patients. Similar to this our study diagnosed all 12 positive cases in MRI.
Ascher SM et al12 study on 20 women, underwent Transvaginal ultrasound and 
MRI Pathological proof obtained in all cases.  17 had adenomyosis. 15/17 cases correctly 
diagnosed in MR. One false positive and 2 false negative diagnosis were made in MR. 
With transvaginal ultrasound 9/17 cases were correctly diagnosed.  One false positive and 
8  false  negative  and  reported  most  frequent  causes  of  false  negative  diagnosis  with 
transvaginal ultrasound is misinterpretation of adenomyosis as leiomyoma.
Similar to the above study, in our study one case considered as fibroid by MRI 
turned out to be focal adenomyoma. Only 7out of 12cases were diagnosed correctly as 
adenomyosis in TV USG because of misinterpretation of adenomyosis as leiomyoma.
Above fact is emphasized by Tamai K, Togashi K etal43 study on MR Imaging 
findings of adenomyosis correlation with histopathologic features and diagnostic pitfalls. 
They  have  reported  pitfalls  in  diagnosis  of  adenomyosis  including  myometrial 
contractions,  leiomyoma,  adenomatoid  tumour,  metastasis,  endometrial  carcinoma and 
endometrial  stromal  sarcoma.   Concluded  that  knowledge  of  various  appearances  of 
adenomyosis  and  the  possible  pitfalls  in  differential  diagnosis  help  guide  the 
determination of appropriate treatment options.
Similar to our study, Mark AS etal44 study on 21 premenopausal patients, 8 had 
adenomyosis,  12 had fibroids and 1 normal.   All  8  adenomyosis  diagnosed on MRI. 
10/12fibroid correctly diagnosed in MRI.  In 2 cases differentiation between adenomyosis 
and fibroid was difficult.
Our study correlates with the study of  Reinhold C etal11 study in which 25/29 
cases  were  diagnosed  positive  for  adenomyosis  in  transvaginal  ultrasound  with  a 
sensitivity  of  86%, specificity  of 86% positive  predictive  value  of  71% and negative 
predictive value of 94%.In Transabdominal ultrasound 21/25 (84%) had heterogenous 
echotexture, 3(12%) had hypoechoic areas with cysts, heterogenous areas in myometrium 
in 1(4%) patient 
Togashi  K,  Ozaga  H  etal7 study  on  93  patients,  71  had  fibroid,  16  had 
adenomyosis, 6 had both fibroid and adenomyosis. In our study on 52 patients 24 had 
fibroid, 12  had adenomyosis,1 had both fibroid and adenomyosis.
Byun JY etal5  study 66.7% (30cases) had diffuse adenomyosis and 33.3% (15) 
had focal adenomyoma.  In diffuse adenomyosis JZ is 7-37mm.High signal intensity foci 
seen in T2 weighted Images only in 4 and on both T1 and T2 weighted images in 11 of 
focal adenomyoma. In comparison to this in our study 10 had diffuse adenomyosis, 2 had 
focal adenomyosis. JZ thickness varies from 10 to 22 mm.
One  patient  had  associated  chocolate  cyst  (Endometriosis)  in  our  study. 
Sugimura K, Okizuka H, Imaoka J, Kaji Y, Takahashi K, Kitao M, Ishida T. et al16 
in their  study on endometriosis  in 35 women concluded that diagnostic accuracy was 
improved with addition of fat saturated images.  So their use together with conventional 
images is recommended in assessment of endometriosis.
In  detecting  endometrial  carcinoma  in  our  study,  MRI  is  100% sensitive  but 
specificity  is  97%.  Kappa is  0.85 with very good agreement.   P<  0.01 statistically 
significant.  The reduction in specificity is because one case considered as endometrial 
carcinoma stage 1a was normal by histopathology in our study.  It showed small hyper 
intense foci breeching the junctional zone.  On retrospective review of the image and 
correlating with the clinical history and HPE report, it was concluded that the MR finding 
may be due to the  fractional curettage done two days earlier.   No contrast imaging was 
done  at  that  time.   This  suggests  that  MRI  finding  does  not  obviate  the  need  of 
endometrial biopsy and fractional curettage which is important in deciding about the final 
diagnosis.  
This  is  emphasized  by  Buyak  E  etal50 and  associates  study  on  endometrial 
disease diagnosed by transvaginal ultrasound and dilatation and curettage concluded that 
fractional curettage seems to be the best method for detecting endometrial abnormalities 
in women with post menopausal bleeding. 
Yamashita Y, Mizutani H etal28 and associates prospectively studied assessment 
of  myometrial  invasion  by  endometrial  carcinoma:  Transvaginal  sonography  versus 
Contrast  enhanced  MR  imaging  in  40  patients  and  classified  depth  of  myometrial 
invasion  stage  E  (Tumours  limited  to  endometrium),  Stage  S  (Superficial  invasion 
tumour invades upto 50% of myometrium),  Stage D deep invasion (Tumour invades 
more  than  50%  of  myometrium).   Compared  the  accuracy  of  TVS,  unenhanced  T2 
weighted (68%) and contrast enhanced (85%) T1 weighted imaging and concluded that 
contrast enhanced T1 weighted MR imaging is significantly superior.
False  positivity  in  T2 weighted  imaging  was due  to  distension  of  endometrial 
cavity  by  pyometra,  the  presence  of  myoma,  atrophy  of  the  myometrium  and  poor 
tumour- myometrium contrast. Increased accuracy in contrast enhanced images was due 
to increased ability to distinguish between tumour, endometrial cavity, tumour invaded 
myometrium and residual  myometrium.  Applying  the  above  findings  to  our  study if 
contrast  enhanced  MRI  had  been  performed  false  positive  diagnosis  of  endometrial 
carcinoma would have been avoided.
Ascher SM49 etal and associates study on uterine changes after  dilatation and 
curettage the MR Imaging findings reported that marked hypointense curvilinear areas in 
the endometrial  canal  on day 2 scans in all  patients,  (P=.0002). By day 7 either they 
decrease  in  size  or  completely  resolve.   No  significant  change  in  the  width  of  the 
endometrial stripe or signal intensity of the junctional zone or myometrium after D&C. 
The junctional zone was focally disrupted in one patient who had complication of uterine 
perforation.
In  another  study  on  diagnosis  of  abnormal  uterine  cavity  concluded  that 
malignancy can be diagnosed when the lesion invaded the myometrial junctional zone or 
lesion enhancement was lower than that of the adjacent myometrium.  
In identifying nabothian cyst comparison between the transabdominal ultrasound, 
and MRI, transabdominal ultrasound was sensitive only in 11% of patients.  Specificity 
cannot be calculated.   Kappa is only 0.2 suggestive of fair agreement.This is because 
penetration  of  ultrasound  waves  is  poor  to  visualize  cervix  better.   On  comparing 
transvaginal ultrasound with MRI the sensitivity is 56%.  Kappa is 0.19. This is because 
when patient  has multiple  lesions with distortion of uterine anatomy identification  of 
nabothian cyst is difficult.  Very small cysts less than 5mm are also picked up in MRI 
because of specific high signal intensity in T2 weighted images and also due to possibility 
of imaging in all three planes.  
In case of carcinoma cervix as all the patients came at or after stage IIb, all cases 
were detected correctly by all the modalities.  But here MR plays  a main role only in 
staging because if vaginal wall  or parametrial  involvement is detected it upgrades the 
staging.   Parametrial  invasion  is  detected  mainly  in  T2  axial  or  contrast  enhanced T1 
weighted axial images because breech in the hypointense line of the outer stroma is better 
seen in axial images.  Vaginal and body extensions are better seen in sagittal and coronal 
images.
        Shiraiwa M etal55 and associates  reported  that  thin  section  oblique  axial  T2 
weighted  images  provide  accurate  cross  section  of  cervix  with  excellent  detail  and 
detected parametrial invasion more accurately than did axial T2 weighted Images. 
Haematometrocolpos are also better seen in T2 weighted or T1 weighted images. 
Fat sat T2 weighted Images and gradient images better demonstrated haematometrocolpos 
in two cases, haematosalphinx is also better visualized in coronal and sagittal images.  
This  finding  can  be  made  use  of  in  diagnosing  haematosalphinx  in  case  of 
primary amenorrhoea.
Outwater GK etal48 in his study on 41 surgically proven patients with dilated 
fallopian tubes looked for MR characteristics of dilated tubes, T1 and T2 weighted FSE 
sequences  were  done.   He evaluated  for  dilated  fallopian  tube,  thickened  tubal  wall, 
mucosal  folds and Signal intensity of intratubal  fluid.   Hyperintense tubal fluid in T1 
weighted sequences corresponds to endometriosis.
In our study one case had large left iliac adenopathy which was eroding the iliac 
bone.  This was thought to be an adnexal mass by transabdominal ultrasound.  But the 
lesion  was  not  reachable  in  transvaginal  ultrasound.   Normal  structures  were  seen 
between the uterus and the mass in transvaginal scan suggesting that the origin of the 
mass is not from adnexa.  But MRI due to it`s large FOV, was able to cover the entire 
area  and  proved  it  to  be  only  iliac  node  with  displacement  of  iliac  vessels  with 
thrombosis.  
This concludes, for staging carcinoma cervix, MRI is the modality of choice and 
if possible contrast enhanced MRI for better detection of extensions.
Two cases were diagnosed as cervical polyp by MRI.  Diagnosis of cervical polyp 
is a clinical one and is not easy with transvaginal and transabdominal ultrasound.  One 
case was prolapsing fundal fibroid with cyst in the pedicle correctly diagnosed by MRI. 
It was diagnosed as nabothian cyst in transvaginal ultrasound.  Another case was fibroid 
polyp arising just above the endo / ecto cervical junction.   It was better delineated in 
coronal MRI.  Exact length of the pedicle can be measured and given to the surgeon. 
Coronal images give a better mental picture to the surgeon for hysteroscopic removal. 
The above finding of better delineation of prolapsing mass by MRI is emphasized 
by the following study. Panageas E, Kier R, Mc cauley TR, Mc carthy S etal30 study 
on submucosal leiomyomas, diagnosis of prolapse into cervix and vagina based on MR 
Imaging  on  5  patients  described  the  MR  appearance,  signs  and  symptoms  and 
pathological  findings of submucosal  leiomyoma that prolapse into cervical  or vaginal 
canal  and concluded that  MR Imaging is  useful for diagnosis  and characterisation of 
uterine leiomyomas that have prolapsed into the cervical or vaginal canal.
The final diagnosis by MRI significantly alters the surgical management.  All the 
lesions of the uterus are better characterised by MRI.  Better localisation of the site and 
exact  number  can  be  detected  with  MRI.  Exact  measurements,  circumference  of  the 
lesion and degenerative  changes can be told by MRI.   The exact  extent  of the mass 
lesions was better depicted in MRI which helps in staging the tumour.
SUMMARY
Transabdominal ultrasound, transvaginal ultrasound and MRI were performed in 
52  patients  referred  for  uterine  mass  lesion  characterisation  from  Department  of 
Obstetrics and Gynaecology. 
 The patients belong to age group ranging from 30 to 65 years.  68% of them were 
premenopausal age group.  Main presenting complaints were pain (69%), bleeding PV 
(37%) and discharge PV (32%).  Infertility present in 9.6%.  46% had dysmenorrhoea. 
Total  patients  were sub grouped into  five  depending upon the  histological  diagnosis. 
Adenomyosis - 12 patients, fibroids - 24 patients, endometrial cancer - 3 patients, cancer 
cervix -  10 patients,  cervical  polyps  -  2 patients.   17 patients  had associated adnexal 
pathology.  In general, comparison of modalities to detect myometrial masses, ultrasound 
is the best screening modality.  Diagonal agreement between transvaginal ultrasound and 
MR is 96%. So transvaginal ultrasound can be used to detect myoma, but to characterise 
myometrial masses diagonal agreement between transvaginal ultrasound and MRI is 67% 
mainly due to mistaken diagnosis of adenomyosis as fibroid in transvaginal ultrasound.
Localising  the  site  of  lesion  and  number  of  lesions  is  best  with  MRI.   For 
submucosal  lesion  detection  MRI  is  the  best.   Sensitivity  of  the  transabdominal 
ultrasound, transvaginal ultrasound and MRI in turn in detecting fibroids is 79%, 100% 
and 100%.  Specificity in turn is 86%, 89%, 96%. So transvaginal ultrasound can be used 
to  detect  fibroid.   But  for  differentiation  of  a  fibroid  from adenomyosis  MRI is  the 
modality of choice.
Among 12 patients with positive adenomyosis all of them were in the age group 
31 to 39 years.  10 had dysmenorrhea.  Junctional zone thickness ranged from 10 – 22 
mms.   Junctional  zone  myometrial  ratio  ranged  from 23-43.  One  case  diagnosed  as 
fibroid by MRI turned out to be focal adenomyoma. Among 12 patients, 10 had diffuse 
adenomyosis and 2 had focal adenomyoma. Only 7 out of 12 patients were diagnosed 
correctly  by  Transvaginal  USG  because  of  misinterpretation  of  adenomyosis  as 
leiomyoma.
Sensitivity  of  transabdominal  ultrasound,  transvaginal  ultrasound  and  MRI  in 
detecting adenomyosis in turn is 33 %, 58% and 92%. So MRI plays a key role in making 
definitive diagnosis of adenomyosis.
In detecting endometrial carcinoma MRI is 100% sensitive and 97% specific. 
 P < 0.01. It is statistically significant.  One case diagnosed as endometrial carcinoma by 
MRI  turned  out  to  be  normal  in  HPE.   Number  of  positive  cases  of  endometrial 
carcinoma is only 3. So there is a need to evaluate more positive cases.  When there is 
endometrial  carcinoma  and  polyp  together  it  can  be  better  characterized  in  MRI. 
Diagnosis of Endometrial carcinoma can be made by all 3 modalities.  But myometrial  
invasion  is  better  detected  by  MRI.   Unenhanced  T2 weighted  imaging  can  upstage 
because of surrounding oedema.  But contrast enhanced T1 weighted imaging will make 
definitive staging. Dilatation & Curettage / fractional curettage is a must in making the 
final diagnosis.  
Nabothian  cyst  can  be  identified  in  all  the  modalities.   But  when patient  has 
distorted uterine anatomy it is better identified in Transvaginal USG with sensitivity of 
56% and MRI with sensitivity of 100%.  Very small cysts are also identified in MRI. 
They usually appear hypo in T1 and hyper in T2 weighted sequences.  In few cases it is 
hyper in both T1 and T2 weighted sequences. 
In case of carcinoma cervix all patients who came for imaging were at or above 
stage II b.  So all modalities correctly diagnosed cancer cervix. But exact staging was 
possible  only  with  MRI.   Oblique  axial  T2  weighted  sequence  was  more  useful. 
Haematometrocolpos was seen in 2 patients.  They also had haematosalphinx.  It is better 
seen with fat saturation T2 weighted sequences and gradient sequences.  One patient had 
large  left  iliac  adenopathy  with  bony  erosion  diagnosed  as  adnexal  mass  in 
transabdominal USG and not reachable in transvaginal USG.  Only MRI diagnosed it 
correctly and also associated displacement of the iliac vessels and thrombosis.
In case of cervical polyp MRI made correct diagnosis regarding the nature of the 
lesion as prolapsing fibroid and also the pedicle length.
To  summarise,  all  lesions  of  the  uterus  are  better  characterized  by  MRI. 
Definitive differentiation of adenomyosis and fibroid is possible with MRI.  Definitive 
staging of malignant lesion is possible with MRI.
CONCLUSION
High spatial  resolution  MR imaging  with  CP spine  Array coil  is  accurate  for 
characterisation, localisation and evaluation of the number of lesions in benign uterine 
mass lesions and for staging of malignant mass lesions.
Pelvic MRI is the best modality to diagnose adenomyosis.  Transabdominal USG 
can be used as a screening modality to diagnose myometrial masses like fibroid.  Calcific 
degeneration is better identified by Transabdominal USG and Transvaginal USG.  Cystic 
degeneration is better identified with Transvaginal USG and MRI.  Submucosal lesions 
are better characterised by MRI than Transvaginal USG.  
In endometrial  lesion detection  Transvaginal  USG can be used as a  screening 
modality.   Transabdominal  USG is  not  useful.   T2 weighted  sequences  and  contrast 
enhanced T1 weighted MRI sequences are useful in lesion characterisation. In cases of 
endometrial carcinoma MRI diagnosis cannot obviate the need for endometrial biopsy. 
Myometrial  invasion  &  extension  of  lesion  are  better  detected  by  MRI  in  case  of 
endometrial carcinoma.
In cervical lesions MRI detects even smaller nabothian cysts than Transvaginal 
USG and Transabdominal USG.  Cervical polyps are accurately diagnosed. Extent of ca 
cervix,  parametrial  invasion,  body  or  vaginal  extension,  haematometrocolpos  and 
haematosalphinx are better detected in MRI than Transvaginal and Transabdominal USG 
which helps in accurate staging.
As the surgical  approach for fibroid and adenomyosis are drastically different, 
MRI should be used in preoperative evaluation of all suspected cases of adenomyosis and 
infertility.
Finally we conclude that pelvic MR Imaging compared to Transabdominal and 
Transvaginal USG is a well tolerated, non invasive and accurate modality to characterise 
uterine mass lesions with excellent histopathological correlation. It is therefore an ideal 
and accurate preoperative imaging modality for characterising, localizing and detecting 
number & extent of uterine mass lesions. 
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ABBREVIATION
MRI - Magnetic Resonance Imaging
TVUSG- Transvaginal ultrasound
USG - Ultrasound
Wt - Weighted
SI - Signal Intensity
Fatsat - Fat saturation 
Ca - Carcinoma
EM - Endometrium
HPE - Histopathological examination
USG - Transabdominal Ultrasound
TV - TransVaginal ultrasound
 MRI - Magnetic Resonance Imaging
MR EVALUATION OF UTERINE MASS LESION IN CORRELATION WITH 
TRANSABDOMINAL, TRANSVAGINAL ULTRASOUND, 
HPE AS GOLD STANDARD.
PROFORMA
Name: Age: Sex:
Occupation: S.No: IP/OP No:
Husband`s Name: Husband`s occupation: Family 
income:
Educational Status: Socio Economics status:
Address:  
HISTORY:
PRESENTING COMPLAINTS
PAIN BLEEDING 
PV
MASS DISCHARGE 
PV
LOSS OF 
WEIGHT
LOSS OF
APPETIT
E
NAUSEA, 
VOMITING
ALTERED 
BOWEL 
HABITS
HISTORY OF PRESENTING ILLNESS:
SYSTEMIC COMPLAINTS:
FEVER CYSTOCELE RECTOCELE URINARY 
RETENTION
STRESS 
INCONTINENCE
MENSTRUAL HISTORY:
Age at menarche _________Yrs.
Post menopausal / Pre menopausal: 
CYCLES:
Regular / Irregular   
If irregular - Amenorrhea
- Polymenorrhoea
- Menorrhagia
- Metrorrhagia
Once in _____ days.  Menstruation lasts for ______ days.
FLOW
NORMAL SCANTY INCREASED INCREASED 
WITH CLOTS
Dysmenorrhea - Yes
- No 
- Associated with drugs.
LMP: ______/_____/_________(dd/mm/yyyy)
Phase of Menstrual cycle - Menstrual 
- Proliferative
- Secretory
MARITAL HISTORY:
Not married __________. Widow __________. Separated ___________.
Married for _________Yrs. Age at Marriage_________Yrs.
Partners _________.
CONTRACEPTIVE HISTORY
History of Contraceptive use: Yes/ No
Type Y/N Duration
Natural
Barrier
OCP
IUCD
OBSTETRIC HISTORY
Total children: Male: Female: 
FTND LCB Abortions  - Induced
                   -       Spontaneous
Ectopic
HISTORY OF INFERTILITY: Yes / No.
Duration:
History of Ovulation induction medication:
PERSONAL HISTORY:
Smoking: Veg / Nonveg
PAST HISTORY:
Hypertension / Diabetes / Tuberculosis.
FAMILY HISTORY:
TREATMENT HISTORY:
Biopsy        RT    Surgery Chemotherapy
GENERAL EXAMINATION:
Build: Weight: Anemia: Lymphadenopathy: Hirsutism:
SYSTEM EXAMINATION:
CVS: RS: CNS:
ABDOMEN EXAMINATION:
Ascites
MASS Size:
Site:
Mobility:
Tenderness:
Adhesion to other structures:
Hepatosplenomegaly:
Others
PR – Rectal  Mucosa Free / Not
Bleeding Mass
PERSPECULUM
CERVIX
ULCER MASS POLYP DISCHARGE BLEEDING
PERVAGINUM
CERVIX: 
UTERUS: AV/RV
Size: normal enlarged
regular    / irregular
Mobility:
Tenderness:
Mass:
Additional adnexal mass / tenderness:
Discharge pv:
ULTRASONOGRAPHY:TRANSABDOMINAL:
UTERUS:
Size:
Contour : Regular  / Lobulated
Endometrium: Homogenous / 
Inhomogenous
                                                                                    Echogenic/   Hypoechoic
Endometrial Thickness:
Endometrial Cavity Fluid: + / -
Mass Lesion: Single / Multiple
Description of the Mass:
Myometrium: Homogenous / 
Inhomogenous
MASS
SUBMUCOSAL:      INTRAMURAL:  SUBSEROSAL:
Hypo 
Echoic
Hyper 
Echoic
Mixed 
Echoic
Areas of 
Calcification
Areas of 
cystic 
Degeneration
Shadowing
+ / -
CYST:
Single Multiple Anterior 
Myometrium
Posterior
Myometrium
Description of the lesion:
Bladder wall indentation: +    /    -
Cervix : Normal / Abnormal 
Mass: +     /   -
OVARIES: RIGHT / LEFT
Visualised:
Mass:
LYMPHADENOPATHY:
OTHER ORGANS:
HYDRONEPHROSIS: RIGHT / LEFT
TRANSVAGINAL ULTRASOUND 
UTERUS:
Endometrium: Homogenous / Inhomogenous
Echogenic / Hypoechoic
Endometrial Thickness:
Endometrial Cavity Fluid: + / -
Mass Lesion: Single / Multiple
Description of the Mass:
Myometrium: Homogenous / 
Inhomogenous
Symmetric / Asymmetric
MASS:
SUBMUCOSAL:      INTRAMURAL:    SUBSEROSAL:
Hypo 
Echoic
Hyper 
Echoic
Mixed 
Echoic
Areas of 
Calcification
Areas of 
cystic 
Degeneration
Shadowing 
+ / -
CYST:
Single Multiple Anterior 
Myometrium
Posterior
Myometrium
 Depth of 
myometrial 
invasion
Description of the lesion:
Bladder wall indentation: +    /    -
Cervix : Normal / Abnormal 
Mass: +     /   -
Nabothian cyst:
OVARIES: RIGHT / LEFT
Visualised:
Mass:
COLOUR DOPPLER:
MAGNETIC RESONANCE IMAGING:
UTERUS:
Borders:
Size:
Uterine symmetry:
Maximal junctional zone thickness:
Junctional zone thickness to myometrial thickness ratio:
LESIONS MYOMETRIUM:
T1 WEIGHTED: T2 WEIGHTED: OTHER SEQUENCE:
ENDOMETRIUM: uniform focal thickening 
ENDOMETRIAL CAVITY: normal distorted
FLUID: +  /  -
CERVIX:
Contour:
Mass:
Soft tissue stranding:
Extension:
Uterine vaginal parametrium
LYMPHADENOPATHY/ASCITES
OVARIES: RIGHT (N/ABN) LEFT (N/ABN)
IF ABNORMAL LESION DESCRIPTION:
TREATMENT:
1. FRACTIONAL CURETTAGE / D & C
2. FOCAL RESECTION
3. HYSTERECTOMY
4. CERVICAL BIOPSY 
DETAILS OF TREATMENTS: OPERATIVE FINDINGS
HISTOPATHOLOGY REPORT:
FINAL OUTCOME:
CLINICAL DIAGNOSIS:
TRANSABDOMINAL USG DIAGNOSIS:
TRANSVAGINAL USG DIAGNOSIS:
COLOUR DOPPLER:
MRI DIAGNOSIS:
PEROPERATIVE DIAGNOSIS:
HISTOPATHOLOGY DIAGNOSIS:
MASTER CHART I A
S.NO. NAME AGE COMP
.
M.
PAUSE
M.
PHASE
CYC DYS.
MEN
MASS
P/A
CERVIX 
P/S
UTE 
SIZE
P/V
        UT SIZE CONTOUR
USG TV MRI USG
1 Kalyani 30 1,2,4 1 3 1 1 0 4 1 2 2 2
2 Kamali 39 1 1 2 1 1 0 0 1 2 2 2
3 Kamatchi 47 2 2 0 2 1 0 0 0 1 1 1
4 Rani 37 1,2,3 1 3 1 1 1 6 1 2 2 2
5 Hemavathy 51 1 2 0 1 0 0 0 1 2 2 2
6 Valli 53 2 2 0 2 0 0 6 0 1 1 1
7 Salma 40 1 2 0 1 0 0 0 0 2 2 2
8 Vimala 42 1 1 3 1 1 0 0 0 2 2 2
9 Selvi 40 1,2 1 3 1 0 0 0 1 2 2 2
10 Saroja 38 1,4 1 2 1 0 0 0 1 2 2 2
11 Sheela 35 0 1 3 1 1 0 0 1 2 2 2
12 Ambika 38 0 1 2 1 0 0 0 1 2 2 2
13 Suryakumari 40 1 1 1 1 0 0 0 1 2 2 2
14 Danammal 65 1 2 0 1 0 0 0 0 1 1 1
15 Kannammal 50 1,4 1 3 1 0 0 7 1 1 1 1
16 Latha 36 4 1 3 1 0 0 0 0 2 2 2
17 Sheela boopathy 35 1 1 2 1 1 0 0 0 2 2 2
18 Sayamma 50 1 2 0 1 0 0 0 0 1 1 1
19 Bhavani 32 1 1 2 1 1 0 0 0 2 2 2
20 Kanagalatha Das 31 1,2 1 3 1 1 0 0 1 1 1 1
21 Latha Raju 35 1 1 2 1 1 0 0 1 2 2 2
22 Nagapoosanam 52 1,2,4,6 2 0 1 0 0 7 0 1 1 1
23 Tulasi 30 1,2 1 3 2 1 0 0 1 2 2 2
24 Rajammal  61 4 2 0 2 1 0 8 1 2 2 2
MASTER CHART I B
S.N
O
EM EM 
THICK
MRI 
JZ 
THICK
JZ/MY
RATIO
%
EM CAV 
FLUID
EM MASS 
LESION
MY
INVASI
MYOMET
ECHO
MYOMET
MASS
USG TV USG TV USG TV MRI USG TV MRI USG TV USG TV MRI
1 1 1 7 11 23 0 0 0 0 0 0 N 2 2 1 2 2
2 2 2 6 6 9 17 0 0 0 0 0 0 N 1 1 0 2 2
3 1 3 9 5 13 0 0 0 0 2 1 2 1 1 0 0 0
4 1 1 0 0 0 0 0 0 N 2 2 2 2 2
5 1 4 8 0 0 0 0 0 0 N 2 2 2 2 2
6 3 3 18 21 N N 0 0 0 1 1 1 3 1 1 0 0 0
7 2 2 4 4 6 14 0 0 0 0 0 0 N 1 1 1 2 2
8 2 2 8 8 5 11 0 0 0 0 0 0 N 1 2 2 2 2
9 2 2 10 10 8 13 0 0 0 0 0 0 N 1 1 1 2 2
10 2 2 9 9 6 11 0 0 0 0 0 0 N 2 2 2 2 2
11 2 2 9 9 5 7 0 0 0 0 0 0 N 2 2 2 2 2
12 1 4 8 8 6 9 0 0 0 0 0 0 N 2 2 2 2 2
13 2 2 3 3 6 8 0 0 0 0 0 0 N 2 2 2 2 2
14 3 3 22 26 3 0 0 0 1 1 1 2 1 1 0 0 0
15 2 2 5 5 5 11 0 0 0 0 0 0 N 1 1 0 0 0
16 2 2 11 11 10 23 0 0 0 0 0 0 N 2 2 1 1 1
17 2 2 13 13 6 15 0 0 0 0 0 0 N 2 2 2 2 2
18 4 4 12 12 7 15 0 0 0 1 1 1 0 1 1 0 1 1
19 2 2 8 8 13 31 0 0 0 0 0 0 N 1 2 0 0 0
20 1 2 7 22 43 0 0 0 0 0 0 N 2 2 1 2 2
21 2 2 8 8 13 26 0 0 0 0 0 0 N 2 2 2 2 2
22 2 2 4 4 4 12 0 0 0 0 0 0 N 1 1 1 0 0
23 1 4 5 4 0 0 0 0 0 0 N 2 2 2 2 2
24 1 1 1 1 1 0 0 0 N 1 1 0 0 0
 
MASTER CHART I C
S.N
O
CYST  DEG SHADOW CYST CERVIX NABOTHIAN 
CYST
CX MASS OVARY SI IN 
MRI
USG TV MRI USG TV USG TV USG TV MRI USG TV MRI USG TV MRI USG TV MRI T1
1 0 1 1 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 2
2 0 0 0 0 0 0 0 1 2 2 0 1 1 0 0 0 0 0 0 0
3 1 1 2 0 0 1 0 0 0 0 0 0 3
4 1 1 1 1 1 0 0 0 1 1 0 0 0 0 0 0 0 0
5 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1
6 1 1 1 0 0 0 0 0 0 1 1 1 0
7 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 2 2 2 0
8 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 1 1 1 0
9 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0
10 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1
11 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 1 1 1 0
12 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1
13 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 1 1 1 0
14 1 1 1 0 0 0 0 0 0 0 0 0 0
15 2 2 2 0 0 0 1 1 1 0 0 0 0
16 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 1 1 1 0
17 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 2 2 2 0
18 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0
19 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0
20 0 0 0 0 1 0 0 1 1 1 0 1 1 0 0 0 0 0 0 0
21 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 1 1 1 4
22 2 2 2 0 0 0 1 1 1 0 0 0 0
23 0 0 1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1
24 2 2 2 0 0 0 1 1 1 0 0 0 0
MASTER CHART II A
S.NO. NAME AGE COMP. M.
PAUSE
M.
PHAS
CYC DYS.
MEN
MASS
P/A
CERVI 
P/S
UTE 
SIZE
P/V
        UT SIZE
USG TV MRI
25 Sankari 35 1 1 2 1 0 0 3 1 2 2 2
26 Raviammal 35 1,2 1 2 2 1 0 3 0 2 2 2
27 Sambanthakumri 53 1,2,3,4,5,6 2 0 1 0 1 8 1 1 1 1
28 Nayinammal 57 2,4 2 0 1 0 0 8 1 2 2 2
29 Maragatham 38 1 1 2 2 1 0 0 1 2 2 2
30 Narayiniammal 59 2,4 2 0 1 0 0 8 1 2 2 2
31 Tamilarasi 36 1 1 2 1 1 0 0 0 2 2 2
32 Vijaya 38 0 1 2 1 0 0 0 1 2 2 2
33 Nagammal 64 2,4,6 2 0 1 0 0 7 0 1 1 1
34 Mathammal 38 1,3 1 2 1 1 1 0 1 2 2 2
35 Saratha 50 1 2 0 1 0 0 0 0 1 1 1
36 L.maheshwari 36 4 1 3 1 0 0 0 0 2 2 2
37 Karthiyayini 31 1,2 1 3 1 1 0 0 1 1 1 1
38 Priya 50 1,4 1 3 1 0 0 7 1 1 1 1
39 Nallamma 59 2,4 2 0 1 0 0 8 1 2 2 2
40 Santhalakshmi 53 2 2 0 2 0 0 6 0 1 1 1
41 Rajeshwari 61 4 2 0 2 1 0 8 1 2 2 2
42 Veerammal 42 1 1 3 1 1 0 0 0 2 2 2
43 Anandalakshmi 38 0 1 2 1 0 0 0 1 2 2 2
44 Karpagam 31 1,2 1 3 1 1 0 0 1 1 1 1
45 Kokila 40 1 2 0 1 0 0 0 0 2 2 2
46 Akilandeshwari 42 1 1 3 1 1 0 0 0 2 2 2
47 Kannathal 40 1,2 1 3 1 0 0 0 1 2 2 2
48 Sartaj 38 1,4 1 2 1 0 0 0 1 2 2 2
49 Parvathy 31 1,4 1 3 1 1 0 4 1 2 2 2
50 Maheshwari 38 1 1 2 2 1 0 0 1 2 2 2
51 Valarmathy 38 0 1 2 1 0 0 0 1 2 2 2
52 Tamilselvi 36 1 1 2 1 1 0 0 0 2 2 2
MASTER CHART II B
S.N
O
EM EM 
THICK
MRI 
JZ 
THICK
JZ/MY
RATIO
%
EM CAV 
FLUID
EM MASS 
LESION
MY
INVASI
MYOMET
ECHO
MYOMET
MASS
IF MASS
USG TV USG TV USG TV MRI USG TV MRI USG TV USG TV MRI USG
25 1 2 6 5 12 0 0 0 0 0 0 N 1 1 0 0 1 0
26 1 2 8 5 11 0 0 0 0 0 0 N 1 1 0 0 0
27 1 2 5 4 10 0 0 1 0 0 0 N 1 1 0 0 0
28 1 1 1 1 1 0 0 0 N 1 1 0 0 0
29 2 2 6 6 5 12 0 0 0 0 0 0 N 2 2 2 2 2 4
30 1 1 1 1 1 0 0 0 N 1 1 0 0 0
31 2 2 8 8 14 31 0 0 0 0 0 0 N 1 2 0 0 0
32 1 4 8 8 6 9 0 0 0 0 0 0 N 2 2 2 2 2 4
33 1 1 2 6 1 1 1 0 0 0 N 1 1 0 0 0
34 2 2 7 7 8 14 0 0 0 0 0 0 N 2 2 2 2 2 4
35 4 4 12 12 7 15 0 0 0 1 1 1 0 1 1 0 1 1
36 2 2 11 11 10 24 0 0 0 0 0 0 N 2 2 1 1 2 2
37 1 2 7 22 41 0 0 0 0 0 0 N 2 2 1 2 2 2
38 2 2 5 5 5 11 0 0 0 0 0 0 N 1 1 0 0 0
39 1 1 1 1 1 0 0 0 N 1 1 0 0 0
40 3 3 18 19 0 0 0 1 1 1 3 1 1 0 0 0
41 1 1 1 1 1 0 0 0 N 1 1 0 0 0
42 2 2 8 8 5 11 0 0 0 0 0 0 N 1 2 2 2 2 2
43 1 4 8 8 6 9 0 0 0 0 0 0 N 2 2 2 2 2 4
44 1 2 7 19 38 0 0 0 0 0 0 N 2 2 1 2 2 2
45 2 2 4 4 6 14 0 0 0 0 0 0 N 1 1 1 2 2 2
46 2 2 8 8 5 11 0 0 0 0 0 0 N 1 2 2 2 2 2
47 2 2 10 10 8 13 0 0 0 0 0 0 N 1 1 1 2 2 2
48 2 2 9 9 6 11 0 0 0 0 0 0 N 2 2 2 2 2 4
49 1 1 7 11 23 0 0 0 0 0 0 N 2 2 1 2 2 2
50 2 2 6 6 5 12 0 0 0 0 0 0 N 2 2 2 2 2 4
51 1 4 8 8 6 9 0 0 0 0 0 0 N 2 2 2 2 2 4
52 2 2 8 8 14 29 0 0 0 0 0 0 N 1 2 0 0 0
MASTER CHART II C
S.NO CYST  DEG SHADOW CYST CERVIX NABOTHIAN 
CYST
CX MASS OVARY SI IN 
MRI
USG TV MRI USG TV USG TV USG TV MRI USG TV MRI USG TV MRI USG TV MRI T1 T2
25 0 2 2 1 1 0 0 1 1 0 0 0 0 5
26 2 2 2 0 0 0 1 1 1 0 0 0 0 4
27 2 2 2 0 0 0 1 1 1 2 0 0 6
28 2 2 2 0 0 0 1 1 1 1 1 1 0 2
29 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
30 2 2 2 0 0 0 1 1 1 1 1 1 0 2
31 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 2
32 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
33 2 2 2 0 0 0 1 1 1 0 0 0 0 2
34 0 1 1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1
35 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
36 0 0 0 0 0 0 1 1 1 1 0 0 1 0 0 0 1 1 1 0 1
37 0 0 0 0 1 0 0 1 1 1 0 1 1 0 0 0 0 0 0 0 1
38 2 2 2 0 0 0 1 1 1 0 0 0 0 2
39 2 2 2 0 0 0 1 1 1 1 1 1 0 2
40 1 1 1 0 0 0 0 0 0 1 1 1 0 2
41 2 2 2 0 0 0 1 1 1 0 0 0 0 2
42 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 1 1 1 0 3
43 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1 1
44 0 0 0 0 1 0 1 1 1 1 0 1 1 0 0 0 0 0 0 0 1
45 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 2 2 2 0 1
46 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 1 1 1 0 3
47 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
48 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 1 1
49 0 1 1 1 1 0 1 1 1 1 0 0 0 0 0 0 0 0 0 2 2
50 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
51 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1
52 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 2
KEY TO MASTER CHART
1. COMP Presenting complaints - Pain - 1
Bleeding PV - 2
Mass - 3
Discharge PV - 4
Loss of weight - 5
Loss of appetite - 6
2. M.PAUSE Menopausal status - Premenopausal - 1
Post menopausal - 2
3. M.PHASE Menstrual phase - Menstrual phase - 1
Proliferative phase - 2
Secretory Phase - 3
4. CYC Cycle - Regular - 1
Irregular - 2
5. DYS.MEN Dysmenorrhoea - Present - 1
Absent - 0
6. MASS P/A Perabdominal mass - Present - 1
Absent - 0
7. CERVIX P/S Perspeculam cervix - Normal - 0
Ulcer –1, Mass – 2, Polyp –3, Discharge –4, Bleeding – 5, Congested – 6,
2 and 4 is 7, 2 and 5 is 8.
8. UTE SIZE P/V – Pervaginum uterine size  Normal - 0
Enlarged - 1
9. UT. SIZE  Uterine size - Normal - 1
 Enlarged - 2
10. CONTOUR - Regular - 1
Irregular - 2
11. SYMMETRY Symmetric - 1
Asymmetric - 2
12. ENDOMETRIUM Not seen - 1
Homogenous - 2
Inhomogenous -  3
13. EM. THICK Endometrial thickness in mm
14. MR  JZ THICK MRI Junctional zone thickness in mm
15. JZ / MY RATIO Junctional zone to myometrial ratio in %
16. EM.CAV.FLUID Endometrial Present - 1
Cavity fluid Absent - 0
17. EM MASS Endometrial mass Present - 1
Absent - 0
18. MY.INVASI Myometrial invasion Not applicable - N 
 
Absent - 1
< 50% - 2
> 50% - 3 
19. MYO.MET. ECHO Myometrial echo Homogenous - 1
Inhomogenous - 2
20. MYO.MET.MASS Myometrial mass Absent - 0
Ill defined - 1
Present - 2
21. If MASS Submucus - 1
Intramural - 2
Subserosal - 3
2&3=4, 1&2=3=5, 1&2=6.
22. ECHO Isointense - 1
Hypointense - 2
Hyperintense - 3
Mixedintense - 4
23. CALC - Calcification in myometrial mass
CYST DEG – Cystic degeneration in myometrial mass 
SHADOW  - shadowing in Myometrial mass
CYST - Myometrial cyst Present - 1
Absent - 0
      24. CERVIX Not visualized -  0
Normal - 1
Abnormal - 2
25.NC in CX Nabothian cyst Present  - 1
     MASS CX Cervical mass Absent - 0
26.OVARY Normal - 0
Cyst - 1
Mass - 2
Not seen - N 
     27.SI in MRI - Signal intensity in MRI:
T1 w - T1 weighted
T2 w - T2 weighted Isointense - O
Hypointense - 1
Hyperintense - 2
Mixed intense - 3
28. T”MT Treatment / Cervical Biopsy - 2
Methods of HPE Endometrial curettage - 3
Myomectomy / polypectomy - 4
Hysterectomy - 5
29. FINAL OUTCOME Normal -           0
Adenomyosis - 1
Fibroid - 2
1 & 2 - 3
Endometrial carcinoma - 4
Endometrial  polyp - 5
4 & 5 - 10
Cervical polyp - 6
 Carcinoma cervix - 7
Inconclusive - 8
USG - Transabdominal ultrasound TV - Transvaginal ultrasound    
MRI -Magnetic resonance imaging. 
